Metrikler
Yayın
439
Açık Erişim
38
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2001 - Devam Ediyor
2001 - Devam EdiyorTıpta Yandal Uzmanlık
Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
1986 - 1992
1986 - 1992Lisans
Çukurova Üniversitesi, Tıp Fakültesi, Türkiye
Araştırma Alanları
Gastroenteroloji-(Hepatoloji)
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Akademik Ünvanlar / Görevler
1992 - Devam Ediyor
1992 - Devam EdiyorProf. Dr.
Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Yönetilen Tezler
2022
2022Tıpta Uzmanlık
Hastaneye yatan siroz hastalarında erken ve geç dönem mortaliteye etki eden faktörler
İdilman R. (Danışman)
B.HAKTANIYAN(Öğrenci)
2022
2022Tıpta Uzmanlık
Alkol ilişkili kronik karaciğer hastalığı seyrine etki eden faktörler
İdilman R. (Danışman)
B.ALPER(Öğrenci)
2020
2020Tıpta Uzmanlık
Kronik hepatit B hastalarında entekavir ve tenofovir tedavi kesimi sonrası hepatit B relaps oranları ve relaps belirleyicilerinin saptanması
İDİLMAN R. (Danışman)
F.TUĞÇE(Öğrenci)
2020
2020Tıpta Uzmanlık
Alkol dışı yağlı karaciğer hastalığında kardiyak ve kardiyovasküler hastalık varlığının önceden saptanması: Subklinik myokardial disfonksiyon
İDİLMAN R. (Danışman)
B.BAHAR(Öğrenci)
2016
2016Tıpta Uzmanlık
Hepatit C virus enfeksiyonuna bağlı dekompanse sirotik ve karaciğer nakil hastalarında sofosbuvir/ledipasvir tedavisinin etkinliği ve tolerabilitesi
İDİLMAN R. (Danışman)
C.EROL(Öğrenci)
2015
2015Tıpta Uzmanlık
Hepatit B enfeksiyonuna bağlı sirotik hastalarda uzun süreli oral antiviral ajan kullanımının hastalık seyrine etkisi
İDİLMAN R. (Danışman)
G.KILIÇ(Öğrenci)
2010
2010Tıpta Uzmanlık
Portal hipertansiyonlu hastalarda transjuguler intrahepatik portosistemik şantın böbrek fonksiyonları bozukluğu ve renal resisitivite indeksi üzerine etkileri
İDİLMAN R. (Danışman)
G.CENGİZ(Öğrenci)
2009
2009Tıpta Uzmanlık
HBE antijen negatif kronik Hepatit B'li hastalarda Lamivudin tedavisinin etkinliği
İDİLMAN R. (Danışman)
Y.BOZKUŞ(Öğrenci)
2008
2008Tıpta Uzmanlık
Kronik hepatit C'li hastalarda karaciğer fibrozisini göstermede kullanılan biyokimyasal belirteçler ile karaciğer biyopsisinin tanısal değerliliklerinin karşılaştırılması
İDİLMAN R. (Danışman)
D.MIZRAK(Öğrenci)
2008
2008Non-alkolik yağlı karaciğeri olanlarda endotelyal fonksiyon bozukluğu ve kardiyovasküler risk profilinin belirlenmesi: metabolik sendrom birlikteliğinin etkinliği
İDİLMAN R. (Danışman)
M.SAYKI(Öğrenci)
2006
2006Tıpta Uzmanlık
Kronik hepatit C'li hastalarda karaciğer yağlanmasının pegile-interferon ile kombine antiviral tedavi yanıtına etkisi
İDİLMAN R. (Danışman)
Ş.ÇOBAN(Öğrenci)
Makaleler
Tümü (267)
SCI-E, SSCI, AHCI (239)
SCI-E, SSCI, AHCI, ESCI (258)
ESCI (18)
Scopus (257)
TRDizin (47)
Diğer Yayınlar (2)
2026
20261. De Novo Malignancies after Liver Transplantation: A Multicenter Cohort Study of Incidence, Timing, and Outcomes
DANIŞ N., DÖNGELLİ H., ÜNEK T., Bacakoğlu A., Turan İ., Karasu A. Z., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.37, sa.4, ss.510-523, 2026 (SCI-Expanded, Scopus, TRDizin)
2026
20262. Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis Cohort
Bajaj J. S., Silvey S., Mullan A., Choudhury A., Wong F., George J., et al.
Clinical Gastroenterology and Hepatology
, cilt.24, sa.2, ss.453, 2026 (SCI-Expanded, Scopus)
2026
20263. Ten-Year Follow-Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT-II): Improved Clinical Outcome After Combination Therapy
Yurdaydin C., Kahlhöfer J., Caruntu F. A., Yalcin K., GÜREL S., Akarca U. S., et al.
United European Gastroenterology Journal
, cilt.14, sa.1, 2026 (SCI-Expanded, Scopus)
2026
20264. Enhancement of Inpatient Mortality Prognostication With Machine Learning in a Prospective Global Cohort of Patients With Cirrhosis With External Validation
Silvey S., Kamath P. S., George J., Choudhury A., Xie Q., Topazian M., et al.
Gastroenterology
, cilt.170, sa.1, ss.148-160, 2026 (SCI-Expanded, Scopus)
2026
20265. Risk Factors for Primary Sclerosing Cholangitis Recurrence Following Liver Transplantation: A Multicenter Retrospective Analysis
Adali G., Acar S., Harputluoğlu M., YILMAZ T. U., KARAKAYALI H., Istemihan Z., et al.
Clinical Transplantation
, cilt.40, sa.1, 2026 (SCI-Expanded, Scopus)
2025
20256. Pre-transplant predictors of 3-Month survival following liver transplantation for acute liver failure in adult and pediatric patients in Türkiye
Turan İ., Akarca U. S., Aladağ M., Harputluoğlu M., YILMAZ S., Gençdal G., et al.
Scientific Reports
, cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)
2025
20257. Histological disease progression in patients with metabolic dysfunction–associated steatotic liver disease using paired liver biopsy
Turan Gokce D., Ekelik M., Gumussoy M., Kiremitci S., Bodakci E., Yilmaz V., et al.
European Journal of Gastroenterology and Hepatology
, 2025 (SCI-Expanded, Scopus)
2025
20258. The impact of long-term potent antiviral therapy on the natural course of disease in patients with hepatitis B virusrelated cirrhosis
Kilic G., Guvenir T., BODAKÇİ E., MELEKOĞLU ELLİK Z., GÖKCAN H., İDİLMAN R.
Hepatology Forum
, cilt.6, sa.4, ss.141-145, 2025 (Scopus)
2025
20259. Efficacy and tolerability of tenofovir alafenamide fumarate prophylaxis in HBV-infected individuals receiving chemo/ immunosuppressive therapy
DİLBER F., DURAK S., DEMİR M., YILDIRIM A. E., MELEKOĞLU ELLİK Z., ADANIR H., et al.
Hepatology forum , 2025 (ESCI, Scopus, TRDizin)
2025
202510. Updates on Recent Advancements in Hepatitis D Virus Treatment
Bardak A. E., Ozturk N. B., Gurakar M., Sequeira L., Yildiz E., Ozmert E. H., et al.
Viruses
, cilt.17, sa.8, 2025 (SCI-Expanded, Scopus)
2025
202511. Hepatic steatosis is associated with HBSAG seroclearance in patients with chronic hepatitis B virus infection but it is also associated with disease progression
Bodakçı E., KİREMİTCİ S., MELEKOĞLU ELLİK Z., Koç Ö., GÜMÜŞSOY M., YILMAZ V., et al.
Hepatology forum , 2025 (ESCI, Scopus, TRDizin)
2025
202512. Ornidazole-Induced Liver Injury: The Clinical Characterization of a Rare Adverse Reaction and Its Implications from a Multicenter Study
Çalışkan A. R., Turan I., Vatansever S., Weninger J., Şamdancı E. T., AKATLI A. N., et al.
Biomedicines
, cilt.13, sa.7, 2025 (SCI-Expanded, Scopus)
2025
202513. Outcomes of Transjugular Intrahepatic Portosystemic Shunt Procedures in a Very-Low-Volume Institution: A Retrospective Single-Center Study
çelebioğlu E. C., ULUDAĞ S., İDİLMAN R., GÖKCAN H., ÜSTÜNER E., MELEKOĞLU ELLİK Z., et al.
Journal of Gastrointestinal and Abdominal Radiology , 2025 (Hakemli Dergi)
2025
202514. Mushroom Intoxication in Türkiye: A Nationwide Cohort Study Based on Demographic Trends, Seasonal Variations, and the Impact of Climate Change on Incidence
Gökçe D., Ari D., Ata N., GÖKCAN H., İDİLMAN R., Ülgü M. M., et al.
Turkish Journal of Gastroenterology
, cilt.36, sa.1, ss.61-66, 2025 (SCI-Expanded, Scopus, TRDizin)
2025
202515. The efficacy of magnetic resonance elastography in predicting oesophageal varices in patients with chronic liver disease
Adigüzel M., ERDEN G. A., KURU ÖZ D., Bodakcı E., İDİLMAN R.
Polish Journal of Radiology
, cilt.90, 2025 (ESCI, Scopus)
2024
202416. Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium
Cao Z., Wong F., Choudhury A. K., Kamath P. S., Topazian M., Torre A., et al.
The Lancet Gastroenterology and Hepatology
, cilt.9, sa.11, ss.997-1009, 2024 (SCI-Expanded, Scopus)
2024
202417. Assessing hepatic steatosis by magnetic resonance in potential living liver donors
Kuru Öz D., Ellik Z., Gürsoy Çoruh A., Adıgüzel M., Gümüşsoy M., Kiremitci S., et al.
Diagnostic and Interventional Radiology
, cilt.30, sa.6, ss.351-356, 2024 (SCI-Expanded, Scopus, TRDizin)
2024
202418. Changing Trends in the Etiology of Cirrhosis in Türkiye: A Multicenter Nationwide Study
Üçbilek E., Yıldırım A. E., Ellik Z., Turan İ., HAKTANIYAN B., Orucu B., et al.
Turkish Journal of Gastroenterology
, cilt.35, sa.10, ss.772-777, 2024 (SCI-Expanded, Scopus, TRDizin)
2024
202419. HOSPITALIZED PATIENTS WITH CIRRHOSIS, ESPECIALLY THOSE NOT IN HIGH INCOME COUNTRIES CONTINUE TO HAVE WORSE OUTCOMES REGARDLESS OF WHETHER OUTCOMES WERE STUDIED DURING AND AFTER THE COVID PANDEMIC
Bajaj J., Xie Q., Kamath P. S., Topazian M., Hayes P. C., Torre Torre A., et al.
HEPATOLOGY
, 2024 (SCI-Expanded, Scopus)
2024
202420. HEPATIC STEATOSIS IS ASSOCIATED WITH HBSAG CLEARANCE IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION
BODAKÇİ E., KİREMİTCİ S., DUMAN S., MELEKOĞLU ELLİK Z., Gumussoy M., GÜVENİR S. T., et al.
HEPATOLOGY
, 2024 (SCI-Expanded, Scopus)
2024
202421. ASSESSMENT OF THE RELATIONSHIP BETWEEN MRI-BASED INTRAMUSCULAR FAT INDICATING SARCOPENIA IN VARIOUS MUSCLE GROUPS AMONG PATIENTS WITH CHRONIC LIVER DISEASE
Er R. E., Akkaya Z., Ünal S., Kuru Öz D., Çelebi M. M., Gökcan H., et al.
HEPATOLOGY
, 2024 (SCI-Expanded, Scopus)
2024
202422. A brief communication of patients with homozygous C282Y mutation-related hereditary hemochromatosis
GÖKCAN H., Oz D., BODAKÇİ E., TUNÇ E., İDİLMAN R.
HEPATOLOGY FORUM
, cilt.5, sa.3, ss.161-164, 2024 (ESCI, Scopus, TRDizin)
2024
202423. A Brief Communication of Patients of Patients with Homozygous C282Y Mutation-Related Hereditary Hemochromatosis.
GÖKCAN H., Öz d. K., BODAKÇİ E., İDİLMAN R.
Hepatology forum
, cilt.5, ss.161-164, 2024 (ESCI, Scopus, TRDizin)
2024
202424. Recurrence of primary sclerosing cholangitis after living donor liver transplantation: experience from turkish registry
Adali G., Harputluoglu M., Kayhan M. A., Gokce D. T., AKARSU M., Daniscomma N., et al.
JOURNAL OF HEPATOLOGY
, 2024 (SCI-Expanded, Scopus)
2024
202425. Patterns and predictors of postacute discharge location other than home in a global cohort of 3, 678 patients hospitalized with cirrhosis
Seto W., Xie Q., Choudhury A. K., Kamath P. S., Topazian M., Hayes P., et al.
JOURNAL OF HEPATOLOGY
, 2024 (SCI-Expanded, Scopus)
2024
202426. Chronic hepatitis delta with normal ALT and hepatitis D viremia: unravelling its natural history
Gulnar M. O., Kamal H., Palom A., Arici S., Esteban R., TUNÇ E., et al.
JOURNAL OF HEPATOLOGY
, 2024 (SCI-Expanded, Scopus)
2024
202427. Portal vein thrombosis increases short-term mortality independent of liver disease severity score among hospitalized patients of decompensated cirrhosis-result from CLEARED consortium
Choudhury A. K., Xie Q., Topazian M., Torre A., Hayes P., Desalegn H., et al.
JOURNAL OF HEPATOLOGY
, 2024 (SCI-Expanded, Scopus)
2024
202428. A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone
Duman S., Kuru D., Gumussoy M., KİREMİTCİ S., GÖKCAN H., Ulas B., et al.
EUROPEAN RADIOLOGY
, cilt.34, sa.6, ss.3882-3888, 2024 (SCI-Expanded, Scopus)
2024
202429. Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease
Noureddin N., Huang D. Q., Bettencourt R., Siddiqi H., Majzoub A. M., Nayfeh T., et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
, sa.12, ss.1521-1526, 2024 (SCI-Expanded, Scopus)
2024
202430. Histological and clinical disease progression in patients with metabolic dysfunction-associated steatotic liver disease using paired liver biopsy
Ekelik M., Gokce D. T., Gumussoy M., KİREMİTCİ S., Bodakci E., Yilmaz V., et al.
JOURNAL OF HEPATOLOGY
, 2024 (SCI-Expanded, Scopus)
2024
202431. DISEASE PROGRESSION IN PATIENTS WITH METABOLIC DYSFUNCTIONASSOCIATED STEATOTIC LIVER DISEASE USING PAIRED LIVER BIOPSY
Turan D., Ekelik M. M., Gumussoy M., Kiremitci S., Bodakci E., Yilmaz V., et al.
GASTROENTEROLOGY
, cilt.166, sa.5, ss.1642, 2024 (SCI-Expanded, Scopus)
2024
202432. Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!
Bajaj J. S., Choudhury A., Kumaran V., Wong F., Seto W. K., Alvares-Da-Silva M. R., et al.
American Journal of Transplantation
, cilt.24, sa.5, ss.733-742, 2024 (SCI-Expanded, Scopus)
2024
202433. A global action agenda for turning the tide on fatty liver disease
Lazarus J. V., Mark H. E., Allen A. M., Arab J. P., Carrieri P., Noureddin M., et al.
Hepatology
, cilt.79, sa.2, ss.502-523, 2024 (SCI-Expanded, Scopus)
2024
202434. Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study
Akarsu M., DOLU S., Harputluoglu M., YILMAZ S., Akyildiz M., Gencdal G., et al.
HEPATOLOGY FORUM
, cilt.5, sa.1, ss.3-6, 2024 (ESCI, Scopus)
2024
202435. Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D
Anastasiou O. E., Caruntu F. A., Curescu M. G., Yalcin K., Akarca U. S., GÜREL S., et al.
Liver International
, cilt.44, sa.1, ss.139-147, 2024 (SCI-Expanded, Scopus)
2024
202436. Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
Lee S. W., Huang D. Q., Bettencourt R., Ajmera V., Tincopa M., Noureddin N., et al.
Alimentary pharmacology & therapeutics
, cilt.59, sa.1, ss.80-88, 2024 (SCI-Expanded, Scopus)
2023
202337. Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study.
Kim B. K., Bergstrom J., Loomba R., Tamaki N., Izumi N., Nakajima A., et al.
Hepatology (Baltimore, Md.)
, cilt.78, sa.6, ss.1858-1866, 2023 (SCI-Expanded, Scopus)
2023
202338. Demonstration of therapy response to radioembolization with 90Y resin microspheres on 68Ga-PSMA PET/MRI in a patient with hepatocellular carcinoma
Özkan E., Demir B., Kuru Öz D., Soydal Ç., Dursun E., Çelebioğlu E. C., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.51, sa.1, ss.316-317, 2023 (SCI-Expanded, Scopus)
2023
202339. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories.
Razavi-Shearer D., Child H., Razavi-Shearer K., Voeller A., Razavi H., Buti M., et al.
Journal of hepatology
, 2023 (SCI-Expanded, Scopus)
2023
202340. MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analyses.
Noureddin N., Ajmera V., Bergstrom J., Bettencourt R., Huang D. Q., Siddiqi H., et al.
Alimentary pharmacology & therapeutics
, cilt.58, sa.9, ss.856-865, 2023 (SCI-Expanded, Scopus)
2023
202341. A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease
Romero-Gómez M., Lawitz E., Shankar R. R., Chaudhri E., Liu J., Lam R. L., et al.
Journal of Hepatology
, cilt.79, sa.4, ss.888-897, 2023 (SCI-Expanded, Scopus)
2023
202342. Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis.
Huang D. Q., Noureddin N., Ajmera V., Amangurbanova M., Bettencourt R., Truong E., et al.
The lancet. Gastroenterology & hepatology
, cilt.8, sa.9, ss.829-836, 2023 (SCI-Expanded, Scopus)
2023
202343. Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial
Dinkelborg K., Kahlhöfer J., Dörge P., Yurdaydin C., Hardtke S., Caruntu F. A., et al.
Liver International
, cilt.43, sa.8, ss.1663-1676, 2023 (SCI-Expanded, Scopus)
2023
202344. Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium
Bajaj J. S., Choudhury A. K., Xie Q., Kamath P. S., Topazian M., Hayes P. C., et al.
The Lancet Gastroenterology and Hepatology
, cilt.8, sa.7, ss.611-622, 2023 (SCI-Expanded, Scopus)
2023
202345. Five years follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D
Anastasiou O. A., Caruntu F. A., Curescu M. G., YALÇIN K., AKARCA U. S., GÜREL S., et al.
JOURNAL OF HEPATOLOGY
, cilt.78, 2023 (SCI-Expanded, Scopus)
2023
202346. Nosocomial infections in cirrhosis are unpredictable and vary based on region of the world: CLEARED study
Bajaj J. S., Wong F., Xie Q., Kamath P. S., Topazian M., Sarin S. K., et al.
JOURNAL OF HEPATOLOGY
, cilt.78, 2023 (SCI-Expanded, Scopus)
2023
202347. Development of metabolic disorders in transplant recipients
Erdemir G., GÖKCAN H., GÜRSOY ÇORUH A., GÜLPINAR B., Ellik Z., Gumussoy M., et al.
JOURNAL OF HEPATOLOGY
, cilt.78, 2023 (SCI-Expanded, Scopus)
2023
202348. Availability and affordability of services affects outcome in hospitalized patients with cirrhosis-results from CLEARED consortium
Choudhury A., Xie Q., Topazian M., Sarin S. K., Hayes P., Torre A., et al.
JOURNAL OF HEPATOLOGY
, cilt.78, 2023 (SCI-Expanded, Scopus)
2023
202349. Stratification of liver fat content in non-alcoholic steatohepatitis patients with significant liver fibrosis using the MEFIB-Index and MRI-PDFF and its association with hepatocellular carcinoma, decompensation, and mortality
Lee S. W., Huang D., Ajmera V., Tincopa M., Bergstrom J., Noureddin N., et al.
JOURNAL OF HEPATOLOGY
, cilt.78, 2023 (SCI-Expanded, Scopus)
2023
202350. The role of PAGE-B score in predicting the development of hepatocelular cancer in patients with chronic delta hepatitis
KESKİN O., Kalkan C., ÖZTÜRK B., Caliskan A., Sahin H., Gumussoy M., et al.
JOURNAL OF HEPATOLOGY
, cilt.78, 2023 (SCI-Expanded, Scopus)
2023
202351. Identification of risk factors for alcohol relapse in liver transplant patients with alcohol-related liver disease
Turan D., GÜNŞAR F., Harputluoglu M., Kabacam G., Gokcan H., Akyildiz M., et al.
JOURNAL OF HEPATOLOGY
, cilt.78, 2023 (SCI-Expanded, Scopus)
2023
202352. Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta
Kalkan Ç., Yılmaz Y., Erdoğan B. D., SAVAŞ B., Yurdcu E., Çalışkan A., et al.
Journal of Viral Hepatitis
, cilt.30, sa.5, ss.406-416, 2023 (SCI-Expanded, Scopus)
2023
202353. TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.
YILMAZ Y., ZEYBEL M., ADALI G., COŞAR A., SERTESEN E., SÜMER H., et al.
Hepatology forum
, cilt.4, sa.Suppl 1, ss.1-32, 2023 (ESCI, TRDizin)
2023
202354. Determining Subclinical Cardiovascular and Cardiac Diseases in Patients with Non-Alcoholic Fatty Liver Disease
Karaoğlan B. B., Tulunay C., Uzun Ç., Peker E., Özyüncü N., Ellik Z., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.34, sa.3, ss.242-253, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202355. Management of Biliary Complications in Liver Transplant Recipients with Duct-To-Duct Anastomosis: A Single-Center Experience
Karakaya M. F., Er E., Kırımker O., Gümüşsoy M., Bodakçi E., Özercan M., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.34, sa.2, ss.177-181, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202356. The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort
Yaras S., Demir M., Barutcu S., Yildirim A. E., GÜREL S., Ucbilek E., et al.
Hepatology Forum
, cilt.4, sa.3, ss.92-96, 2023 (Scopus)
2023
202357. Diagnosis and Treatment of Autoimmune Hepatitis: Questions, Answers, and Illustrative Cases: Endorsed by Autoimmune Liver Diseases Special Interest Group, Turkish Association for the Study of Liver
Özaslan E., Günşar F., ÇİFCİBAŞI ÖRMECİ A., Hatemi İ., Efe C., AKYOL G., et al.
Turkish Journal of Gastroenterology
, cilt.34, 2023 (SCI-Expanded, Scopus, TRDizin)
2022
202258. Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome
Efe C., Kulkarni A. V., Terziroli Beretta-Piccoli B., Magro B., Stättermayer A., Cengiz M., et al.
Hepatology
, cilt.76, sa.6, ss.1576-1586, 2022 (SCI-Expanded, Scopus)
2022
202259. Factors associated with the development of extrahepatic malignancy in patients with nonalcoholic fatty liver disease: a single-center longitudinal study
Gumussoy M., Koc O., KARATAŞ G., Ozercan M., Ellik Z., DUMAN S., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.34, sa.11, ss.1172-1177, 2022 (SCI-Expanded, Scopus)
2022
202260. DIFFERENCES IN MORTALITY RATES IN INPATIENTS WITH CIRRHOSIS DEPENDS ON THE LOW, MIDDLE OR HIGH INCOME COUNTRY LOCATION: MULTI-NATIONAL CLEARED CONSORTIUM EXPERIENCE
Bajaj J. S., Wong F., Xie Q., Topazian M., Aldo T., İDİLMAN R., et al.
HEPATOLOGY
, cilt.76, 2022 (SCI-Expanded, Scopus)
2022
202261. NATURAL DISEASE OUTCOMES IN PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE: A STUDY WITH PAIRED LIVER BIOPSIES
Gumussoy M., Gokce D., Ekelik M., KİREMİTCİ S., Bodakci E., DUMAN S., et al.
HEPATOLOGY
, cilt.76, 2022 (SCI-Expanded, Scopus)
2022
202262. Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis
Cavazos K., Eswaran S., Maidlow C., KEKLİK KARADAĞ F., İDİLMAN R., İDİLMAN İ. S., et al.
BLOOD ADVANCES
, cilt.6, sa.20, ss.5630-5633, 2022 (SCI-Expanded, Scopus)
2022
202263. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
Ajmera V., Kim B. K., Yang K., Majzoub A. M., Nayfeh T., Tamaki N., et al.
Gastroenterology
, cilt.163, sa.4, ss.1079, 2022 (SCI-Expanded, Scopus)
2022
202264. EFFECT OF PROGNOSTIC NONINVASIVE TESTS ON DISEASE OUTCOME OF ALCOHOL-RELATED LIVER DISEASE
Zengin B. A., Gumussoy M., Duman S., Bodakçi E., Güvenir S. T., Ellik Z., et al.
HEPATOLOGY
, 2022 (SCI-Expanded, Scopus)
2022
202265. LOW SERUM ALBUMIN AT ADMISSION IS ASSOCIATED WITH MORTALITY AMONG INPATIENTS WITH CIRRHOSIS: A MULTI-NATIONAL EXPERIENCE
Wong F., Choudhury A. K., Xie Q., İDİLMAN R., George J., Kouacou M. J. D. L. E., et al.
HEPATOLOGY
, cilt.76, 2022 (SCI-Expanded, Scopus)
2022
202266. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis
Efe C., Taşçılar K., Gerussi A., Bolis F., Lammert C., Ebik B., et al.
Journal of Autoimmunity
, cilt.132, 2022 (SCI-Expanded, Scopus)
2022
202267. FUNCTIONAL CURE WITH LONAFARNIB-BASED THERAPY IN CHRONIC HEPATITIS DELTA
Yurdaydin C., Yurdcu E., Gumussoy M., KESKİN O., Gencdal G., Akyildiz M., et al.
HEPATOLOGY
, cilt.76, 2022 (SCI-Expanded, Scopus)
2022
202268. MEFIB AND MAST SCORES ASSESSMENT OF INCIDENT LIVER-RELATED OUTCOMES IN NONALCOHOLIC FATTY LIVER DISEASE: AN INDIVIDUAL PATIENT META-ANALYSIS
Noureddin N., Ajmera V., Bergstrom J., Huang D., Siddiqi H., Majzoub A., et al.
HEPATOLOGY
, cilt.76, 2022 (SCI-Expanded, Scopus)
2022
202269. Eliminating Viral Hepatitis in Turkey: Achievements and Challenges
AKARCA U. S., BAYKAM N., GÜNER H. R., GÜNŞAR F., İDİLMAN R., Kaymakoglu S., et al.
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
, cilt.28, sa.2, ss.14-21, 2022 (ESCI, TRDizin)
2022
202270. NSAID-associated drug-induced liver injury prior to and following liver transplantation
Gumussoy M., GÖKCAN H., BODAKÇİ E., KİREMİTCİ S., SAVAŞ B., İDİLMAN R.
HEPATOLOGY FORUM
, cilt.3, sa.3, ss.108-109, 2022 (ESCI)
2022
202271. Characteristics of patients with hepatocellular carcinoma: A multicenter study
Guzelbulut F., KARAOĞULLARINDAN Ü., AKKIZ H., ALTINTAŞ E., DEMİRTAŞ C. Ö., Bahadir O., et al.
HEPATOLOGY FORUM
, cilt.3, sa.3, ss.71-76, 2022 (ESCI, Scopus, TRDizin)
2022
202272. The course of COVID-19 infection in patients with chronic hepatitis B and Delta
PARLAR Y. E., KESKİN O., KIRMIZIGÜL B., Gencdal G., Zeybel M., Gumussoy M., et al.
JOURNAL OF HEPATOLOGY
, cilt.77, 2022 (SCI-Expanded, Scopus)
2022
202273. Effectiveness of MRI methods in the assessment of hepatic steatosis in living liver donors
KURU ÖZ D., Ellik Z. M., Coruh A. G., ADIGÜZEL M., Gumussoy M., DUMAN S., et al.
JOURNAL OF HEPATOLOGY
, cilt.77, 2022 (SCI-Expanded, Scopus)
2022
202274. Liver stiffness on magnetic resonance elastography and liver-related outcomes in nonalcoholic fatty liver disease: a systematic review and meta-analysis of individual participants
Ajmera V., Yang K., Kim B. K., Majzoub A., Tamaki N., Nakajima A., et al.
JOURNAL OF HEPATOLOGY
, cilt.77, 2022 (SCI-Expanded, Scopus)
2022
202275. Chronic hepatitis delta with normal ALT and hepatitis D viremia
Arici S., Palom A., Gumussoy M., İDİLMAN R., Gencdal G., Esteban R., et al.
JOURNAL OF HEPATOLOGY
, cilt.77, 2022 (SCI-Expanded, Scopus)
2022
202276. A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis
Yurdaydin C., Keskin O., Yurdcu E., Caliskan A., Onem S., Karakaya F., et al.
HEPATOLOGY
, cilt.75, sa.6, ss.1551-1565, 2022 (SCI-Expanded, Scopus)
2022
202277. Global multi-stakeholder endorsement of the MAFLD definition
Méndez-Sánchez N., Bugianesi E., Gish R. G., Lammert F., Tilg H., Nguyen M. H., et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY
, cilt.7, sa.5, ss.388-390, 2022 (SCI-Expanded, Scopus)
2022
202278. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis
Efe C., Lammert C., Taşçılar K., Dhanasekaran R., Ebik B., Higuera-de la Tijera F., et al.
Liver International
, cilt.42, sa.3, ss.607-614, 2022 (SCI-Expanded, Scopus)
2022
202279. An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
Kim H. Y., Lampertico P., Nam J. Y., Lee H., Kim S. U., Sinn D. H., et al.
JOURNAL OF HEPATOLOGY
, cilt.76, sa.2, ss.311-318, 2022 (SCI-Expanded, Scopus)
2022
202280. Evaluation of Magnetic Resonance Elastography and Transient Elastography for Liver Fibrosis and Steatosis Assessments in the Liver Transplant Setting
Ellik Z., İDİLMAN İ. S., Kartal A., Balaban Y., ELHAN A. H., KARÇAALTINCABA M., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.33, sa.2, ss.153-160, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202281. Advancing the global public health agenda for NAFLD: a consensus statement
Lazarus J. V., Mark H. E., Anstee Q. M., Arab J. P., Batterham R. L., Castera L., et al.
Nature Reviews Gastroenterology and Hepatology
, cilt.19, sa.1, ss.60-78, 2022 (SCI-Expanded, SSCI, Scopus)
2021
202182. Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery
ÖZBAŞ B., Keskin O., Hecker H., Karahan I., ÖZBAŞ C., Kalkan C., et al.
HEPATOLOGY INTERNATIONAL
, cilt.15, ss.1442-1455, 2021 (SCI-Expanded, Scopus)
2021
202183. Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study
AKARCA U. S., Unsal B., Sezgin O., Yalcin K., Akdogan M., Gonen C., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.32, sa.12, ss.1019-1028, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202184. HBV/HDV management after liver transplantation: Review
Muhammad H., Zaffar D., Tehreem A., Peng-Sheng T., ŞİMŞEK C., GÖKCAN H., et al.
Journal of Liver Transplantation , 2021 (Hakemli Dergi)
2021
202185. Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B
Jang H., Yoon J. S., Park S. Y., Lee H. A., Jang M., Kim S. U., et al.
Clinical Gastroenterology and Hepatology
, cilt.74, 2021 (SCI-Expanded, Scopus)
2021
202186. Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation
AKARSU M., Onem S., TURAN İ., Adali G., Akdogan M., Akyildiz M., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.32, sa.9, ss.712-719, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202187. The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study.
Idilman I. S., Celik A., Savas B., Idilman R., Karcaaltincaba M.
Clinical radiology
, cilt.76, sa.9, 2021 (SCI-Expanded, Scopus)
2021
202188. The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts
Kim H. Y., Lampertico P., Nam J. Y., Lee H., Kim S. U., Jang E. S., et al.
JOURNAL OF HEPATOLOGY
, cilt.75, 2021 (SCI-Expanded, Scopus)
2021
202189. Hepatitis D Infection in Asia: A Perspective From an Endemic Region
GÖKCAN H., İDİLMAN R.
Clinical Liver Disease
, cilt.18, sa.1, ss.26-29, 2021 (Scopus)
2021
202190. Covid-19 in Liver Transplant Recipients: A National Cohort
Kabacam G., TURAN İ., KIYICI M., Ellik Z., DOLU S., Dayangac M., et al.
JOURNAL OF HEPATOLOGY
, cilt.75, 2021 (SCI-Expanded, Scopus)
2021
202191. Etiology of Cirrhosis in Turkey: A National Cohort Study
YILDIRIM A. E., ÜÇBİLEK E., Oruncu M. B., TURAN İ., DEMİR M., Koksal A., et al.
JOURNAL OF HEPATOLOGY
, cilt.75, 2021 (SCI-Expanded, Scopus)
2021
202192. Association between non-alcoholic fatty liver disease and extrahepatic malignancy
Gumussoy M., İDİLMAN R., GÖKCAN H., Gokce D., Ulas B. B., Koc O., et al.
JOURNAL OF HEPATOLOGY
, cilt.75, 2021 (SCI-Expanded, Scopus)
2021
202193. Outcomes and characteristics of hepatocellular carcinomas (HCC) in Caucasian chronic hepatitis B (CHB) patients treated with long-term entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy
Papatheodoridis G., Dalekos G., İDİLMAN R., Sypsa V., Buti M., Calleja Panero J. L., et al.
JOURNAL OF HEPATOLOGY
, cilt.75, 2021 (SCI-Expanded, Scopus)
2021
202194. Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study
Efe C., Dhanasekaran R., Lammert C., Ebik B., Higuera-de la Tijera F., Aloman C., et al.
HEPATOLOGY
, cilt.73, sa.6, ss.2099-2109, 2021 (SCI-Expanded, Scopus)
2021
202195. Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B
Papatheodoridis G., Dalekos G. N., İDİLMAN R., Sypsa V., Van Boemmel F., Buti M., et al.
JHEP REPORTS
, cilt.3, sa.3, 2021 (ESCI, Scopus)
2021
202196. Natural History of Cirrhosis: Changing Trends in Etiology Over the Years
İDİLMAN R., Aydogan M., Oruncu M. B., Kartal A., ELHAN A. H., Ellik Z., et al.
DIGESTIVE DISEASES
, cilt.39, sa.4, ss.358-365, 2021 (SCI-Expanded, Scopus)
2021
202197. Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study
Bremer B., Anastasiou O. E., Hardtke S., Caruntu F. A., Curescu M. G., YALÇIN K., et al.
LIVER INTERNATIONAL
, cilt.41, sa.2, ss.295-299, 2021 (SCI-Expanded, Scopus)
2021
202198. Clinical significance of concomitant extrahepatic autoimmune disease in patients with autoimmune liver disease
KARAKAYA M. F., USTA Ş., ÖZTÜRK Y., KALKAN Ç., MELEKOĞLU ELLİK Z., ELHAN A. H., et al.
Hepatology Forum
, cilt.1, sa.2, ss.3-6, 2021 (ESCI)
2021
202199. The Prevalence of Metabolic Associated Fatty Liver Disease in The Turkish Population: A Multicenter Study
YILMAZ Y., YILMAZ N., ATEŞ F., KARAKAYA M. F., GÖKCAN H., KAYA E., et al.
Hepatology forum
, cilt.2, sa.2, ss.37-42, 2021 (ESCI, Scopus)
2021
2021100. Immunoglobulin light chain amyloidosis presenting as Budd-Chiari syndrome
Ozercan M., Eser I., KİREMİTCİ S., PEYNİRCİOĞLU B., Karayalcin S., İDİLMAN R.
Hepatology Forum
, cilt.2, sa.3, ss.120-121, 2021 (Scopus)
2021
2021101. MRI quantification techniques in fatty liver: the diagnostic performance of hepatic T1, T2, and stiffness measurements in relation to the proton density fat fraction
Erden A., KURU ÖZ D., PEKER E., Kul M., Ates F. S. O., Erden I., et al.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY
, cilt.27, sa.1, ss.7-14, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
2021102. Hepatitis D virus and liver transplantation: Indications and outcomes
Muhammad H., Tehreem A., Hammami M. B., Ting P., Idilman R., Gurakar A.
WORLD JOURNAL OF HEPATOLOGY
, cilt.13, sa.3, ss.291-299, 2021 (ESCI, Scopus)
2021
2021103. ATA Index: A novel score for predicting fibrosis stage in chronic viral hepatitis
Tugsal H. Y., YÜKSEL S., Kabacam G., Evirgen S., Akan K., AKYÜZ F., et al.
HEPATOLOGY FORUM
, sa.1, ss.12-19, 2021 (ESCI)
2020
2020104. Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta
Wranke A., Hardtke S., Heidrich B., Dalekos G., YALÇIN K., Tabak F., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.27, sa.12, ss.1359-1368, 2020 (SCI-Expanded, Scopus)
2020
2020105. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
Fan R., Papatheodoridis G., Sun J., Innes H., Toyoda H., Xie Q., et al.
JOURNAL OF HEPATOLOGY
, cilt.73, sa.6, ss.1368-1378, 2020 (SCI-Expanded, Scopus)
2020
2020106. Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience
Degertekin B., DEMİR M., AKARCA U. S., Kani H. T., ÜÇBİLEK E., Yildirim E., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.31, sa.12, ss.883-893, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
2020107. Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B
Papatheodoridis G., Dalekos G. N., İDİLMAN R., Sypsa V., Van Boemmel F., Buti M., et al.
JOURNAL OF HEPATOLOGY
, cilt.73, sa.5, ss.1037-1045, 2020 (SCI-Expanded, Scopus)
2020
2020108. Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B
Papatheodoridis G. V., Sypsa V., Dalekos G. N., Yurdaydin C., Van Boemmel F., Buti M., et al.
JOURNAL OF HEPATOLOGY
, cilt.72, sa.6, ss.1088-1096, 2020 (SCI-Expanded, Scopus)
2020
2020109. The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists
Kabacam G., Dayangac M., ÜÇBİLEK E., Ercin C. N., Gunsar F., Akyilchz M., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.31, sa.5, ss.348-355, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
2020110. A micro-elimination approach to addressing hepatitis C in Turkey
İDİLMAN R., Razavi H., Robbins-Scott S., AKARCA U. S., Ormeci N., Kaymakoglu S., et al.
BMC HEALTH SERVICES RESEARCH
, cilt.20, sa.1, 2020 (SCI-Expanded, Scopus)
2020
2020111. Metabolomics and microbial composition increase insight into the impact of dietary differences in cirrhosis
Cox I. J., İDİLMAN R., Fagan A., Turan D., Ajayi L., Le Guennec A. D., et al.
LIVER INTERNATIONAL
, sa.2, ss.416-427, 2020 (SCI-Expanded, Scopus)
2020
2020112. The role of PNPLA3 (rs738409) cg variant on histological progression of non-alcoholic fatty liver disease
İDİLMAN R., ÖZEN KARATAYLI S. C., KABAÇAM G., SAVAŞ B., ELHAN A. H., BOZDAYI A. M.
Hepatology Forum
, cilt.1, sa.3, ss.82-87, 2020 (ESCI, TRDizin)
2020
2020113. The natural course of non-alcoholic fatty liver disease
Cengiz Seval G., Kabaçam G., Yakut M., Seven G., Savaş B., Elhan A. H., et al.
Hepatology Forum
, cilt.1, sa.1, ss.20-24, 2020 (ESCI, TRDizin)
2020
2020114. A rare disease that presents with acute severe hepatitis: Kikuchi-Fujimoto disease
ÇALIŞKAN KARTAL A., İDİLMAN R., MELEKOĞLU ELLİK Z., SAĞLAM A., CİVRİZ BOZDAĞ S.
Hepatology forum
, cilt.1, ss.41-42, 2020 (Scopus)
2019
2019115. Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort
İDİLMAN R., DEMİR M., ALADAĞ M., Erol C., Cavus B., Iliaz R., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.26, sa.6, ss.666-674, 2019 (SCI-Expanded, Scopus)
2019
2019116. Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
Wedemeyer H., Yurdaydin C., Hardtke S., Caruntu F. A., Curescu M. G., YALÇIN K., et al.
LANCET INFECTIOUS DISEASES
, cilt.19, sa.3, ss.275-286, 2019 (SCI-Expanded, Scopus)
2019
2019117. Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up
van Campenhout M. J. H., Brouwer W. P., Xie Q., Guo S., Chi H., Qi X., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.26, sa.1, ss.109-117, 2019 (SCI-Expanded, Scopus)
2019
2019118. Hepatitis B Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Regimens Containing Lenalidomide and/or Bortezomib
Atilla P. A., Yalciner M., Atilla E., İDİLMAN R., BEKSAÇ M.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.36, sa.4, ss.266-273, 2019 (SCI-Expanded, Scopus, TRDizin)
2018
2018119. Health-related Quality of Life of Liver Donors: A Prospective Longitudinal Study
Hesimov I., Kirimker E. O., Duman B., Keskin O., ÇETİNKAYA Ö. A., Hayme S., et al.
TRANSPLANTATION PROCEEDINGS
, cilt.50, sa.10, ss.3076-3081, 2018 (SCI-Expanded, Scopus)
2018
2018120. Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy
Lutterkort G. L., Wranke A., Hengst J., Yurdaydin C., Stift J., Bremer B., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.25, sa.11, ss.1384-1394, 2018 (SCI-Expanded, Scopus)
2018
2018121. Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort
Bajaj J. S., İDİLMAN R., Mabudian L., Hood M., Fagan A., Turan D., et al.
HEPATOLOGY
, sa.1, ss.234-247, 2018 (SCI-Expanded, Scopus)
2018
2018122. Serum biomarkers for the evaluation of liver fibrosis: The need for better tests
Zeybel M., İDİLMAN R.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.29, sa.4, ss.377-378, 2018 (SCI-Expanded, Scopus, TRDizin)
2018
2018123. Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population
Papatheodoridis G. V., Sypsa V., Dalekos G., Yurdaydin C., van Boemmel F., Buti M., et al.
JOURNAL OF HEPATOLOGY
, cilt.68, sa.6, ss.1129-1136, 2018 (SCI-Expanded, Scopus)
2018
2018124. Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study
Yurdaydin C., Keskin O., Kalkan C., Karakaya F., Caliskan A., Karatayli E., et al.
HEPATOLOGY
, sa.4, ss.1224-1236, 2018 (SCI-Expanded, Scopus)
2018
2018125. Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease
Yurdaydin C., Keskin O., Kalkan C., Karakaya F., Caliskan A., Kabacam G., et al.
JOURNAL OF INFECTIOUS DISEASES
, sa.8, ss.1184-1192, 2018 (SCI-Expanded, Scopus)
2017
2017126. Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines
TABAK Ö. F., Yurdaydin C., KAYMAKOĞLU S., Tabak F., Akarsu M., Akinci E. G., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, 2017 (SCI-Expanded, Scopus, TRDizin)
2017
2017127. Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines
Yurdaydin C., Tabak F., KAYMAKOĞLU S., TABAK Ö. F., Akarsu M., Akinci E. G., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, 2017 (SCI-Expanded, Scopus, TRDizin)
2017
2017128. Turkey 2017 Clinical Practice Guidelines on recommendations for screning diagnosing and managing hepatitis C virus
Idilman R., Baykam N., KAYMAKOĞLU S., Tabak F., Bahcecioglu H. I., Bektas A., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, 2017 (SCI-Expanded, Scopus, TRDizin)
2017
2017129. Recommendation for treatment of hepatitis C virus infection
KAYMAKOĞLU S., Koksal I., KAYMAKOĞLU S., Tabak F., AKARCA U. S., Akbulut A., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, 2017 (SCI-Expanded, Scopus, TRDizin)
2017
2017130. The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B
Papatheodoridis G. V., İDİLMAN R., Dalekos G. N., Buti M., Chi H., van Boemmel F., et al.
HEPATOLOGY
, cilt.66, sa.5, ss.1444-1453, 2017 (SCI-Expanded, Scopus)
2017
2017131. Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines
İDİLMAN R.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, sa.6, ss.518-521, 2017 (SCI-Expanded, Scopus, TRDizin)
2017
2017132. The summarized of EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
İDİLMAN R.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, sa.5, ss.412-416, 2017 (SCI-Expanded, Scopus, TRDizin)
2017
2017133. Pharmacokinetics and Pharmacodynamics Modeling of Lonafarnib in Patients With Chronic Hepatitis Delta Virus Infection
Canini L., Koh C., Cotler S. J., Uprichard S. L., Winters M. A., Han M. A. T., et al.
HEPATOLOGY COMMUNICATIONS
, cilt.1, sa.4, ss.288-292, 2017 (SCI-Expanded, Scopus)
2017
2017134. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study
Blach S., Zeuzem S., Manns M., Altraif I., Duberg A., Muljono D. H., et al.
The Lancet Gastroenterology and Hepatology
, cilt.2, sa.3, ss.161-176, 2017 (SCI-Expanded, Scopus)
2017
2017135. Non-invasive fibrosis score for hepatitis delta
Lutterkort G. L., Wranke A., Yurdaydin C., Budde E., Westphal M., Lichtinghagen R., et al.
LIVER INTERNATIONAL
, cilt.37, sa.2, ss.196-204, 2017 (SCI-Expanded, Scopus)
2017
2017136. Daclatasvir Plus Asunaprevir Dual Therapy for Chronic HCV Genotype 1b Infection: Results of Turkish Early Access Program
Koklu S., Koksal I., AKARCA U. S., BALKAN A., Guner R., Demirezen A., et al.
ANNALS OF HEPATOLOGY
, cilt.16, sa.1, ss.71-76, 2017 (SCI-Expanded, Scopus)
2017
2017137. Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up
Karakaya F., Ozer S., Kalkan C., Tuzun E. A., Caliskan A., Keskin O., et al.
ANTIVIRAL THERAPY
, sa.7, ss.559-570, 2017 (SCI-Expanded, Scopus)
2016
2016138. Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B
Marcellin P., Ahn S. H., Chuang W. -., Hui A. J., TABAK Ö. F., Mehta R., et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
, cilt.44, sa.9, ss.957-966, 2016 (SCI-Expanded, Scopus)
2016
2016139. The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence
İDİLMAN R., Akyildiz M., Keskin O., Gungor G., Yilmaz T. U., Kalkan C., et al.
CLINICAL TRANSPLANTATION
, cilt.30, sa.10, ss.1216-1221, 2016 (SCI-Expanded, Scopus)
2016
2016140. Stone-containing Cystic Mass at the Portal Hilus of the Liver in an Asymptomatic Young Female Patient Duplication of the Gallbladder
İDİLMAN R., Erden A., Karakaya F.
GASTROENTEROLOGY
, sa.2, 2016 (SCI-Expanded, Scopus)
2016
2016141. Comparison of survival, safety, and efficacy after transarterial chemoembolization and radioembolization of Barcelona Clinic Liver Cancer stage B-C hepatocellular cancer patients
SOYDAL Ç., Arslan M. F., KÜÇÜK N. Ö., İDİLMAN R., Bilgic S.
NUCLEAR MEDICINE COMMUNICATIONS
, cilt.37, sa.6, ss.646-649, 2016 (SCI-Expanded, Scopus)
2016
2016142. PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
Papatheodoridis G., Dalekos G., Sypsa V., Yurdaydin C., Buti M., Goulis J., et al.
JOURNAL OF HEPATOLOGY
, cilt.64, sa.4, ss.800-806, 2016 (SCI-Expanded, Scopus)
2016
2016143. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease
İDİLMAN İ. S., Keskin O., Celik A., SAVAŞ B., ELHAN A. H., İDİLMAN R., et al.
ACTA RADIOLOGICA
, cilt.57, sa.3, ss.271-278, 2016 (SCI-Expanded, Scopus)
2016
2016144. Latest updates on chronic viral hepatitis B
İDİLMAN R., Karakaya F.
MARMARA MEDICAL JOURNAL
, cilt.29, ss.33-37, 2016 (ESCI, Scopus, TRDizin)
2015
2015145. Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome
Keskin O., Wedemeyer H., Tuzun A., Zachou K., Deda X., Dalekos G. N., et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
, cilt.13, sa.13, ss.2342-2351, 2015 (SCI-Expanded, Scopus)
2015
2015146. Sequential development of acute autoimmune hepatitis may lead to a serious clinical picture in primary biliary cirrhosis
Keskin O., İDİLMAN R.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.27, sa.10, ss.1228-1229, 2015 (SCI-Expanded, Scopus)
2015
2015147. Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
Koh C., Canini L., Dahari H., Zhao X., Uprichard S. L., Haynes-Williams V., et al.
LANCET INFECTIOUS DISEASES
, cilt.15, sa.10, ss.1167-1174, 2015 (SCI-Expanded, Scopus)
2015
2015148. Therapy of Delta Hepatitis
Yurdaydin C., İDİLMAN R.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE
, cilt.5, sa.10, 2015 (SCI-Expanded, Scopus)
2015
2015149. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease
İDİLMAN İ. S., Tuzun A., SAVAŞ B., ELHAN A. H., Celik A., İDİLMAN R., et al.
ABDOMINAL IMAGING
, cilt.40, sa.6, ss.1512-1519, 2015 (SCI-Expanded, Scopus)
2015
2015150. Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy
SOYDAL Ç., Keskin O., KÜÇÜK N. Ö., ÖZKAN E., Bilgic S., İDİLMAN R., et al.
ANNALS OF NUCLEAR MEDICINE
, cilt.29, sa.5, ss.426-430, 2015 (SCI-Expanded, Scopus)
2015
2015151. Adding Pegylated Interferon to Entecavir for Hepatitis B e Antigen-Positive Chronic Hepatitis B: A Multicenter Randomized Trial (ARES Study)
Brouwer W. P., Xie Q., Sonneveld M. J., Zhang N., Zhang Q., TABAK Ö. F., et al.
HEPATOLOGY
, cilt.61, sa.5, ss.1512-1522, 2015 (SCI-Expanded, Scopus)
2015
2015152. Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naive chronic hepatitis B patients in the real-world setting
Idilman R., Gunsar F., Koruk M., Keskin O., Meral C. E., Gulsen M., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.22, sa.5, ss.504-510, 2015 (SCI-Expanded, Scopus)
2015
2015153. Interleukin-28 gene polymorphisms may contribute to HBsAg persistence and the development of HBeAg-negative chronic hepatitis B
Karatayli S. C., Bozdayi M., Karatayli E., ÖZTÜRK T., Husseini A. A., ALBAYRAK DELİALİOĞLU R., et al.
LIVER INTERNATIONAL
, cilt.35, sa.3, ss.846-853, 2015 (SCI-Expanded, Scopus)
2015
2015154. Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: A computed tomography angiography study
İdilman R., Akata D., Hazırolan T., Doğanay B., Aytemir K., Karçaaltıncaba M.
JOURNAL OF DIABETES , cilt.7, sa.2, ss.279-286, 2015 (SCI-Expanded, Scopus)
2015
2015155. Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
Papatheodoridis G. V., Dalekos G. N., Yurdaydin C., Buti M., Goulis J., Arends P., et al.
JOURNAL OF HEPATOLOGY
, cilt.62, sa.2, ss.363-370, 2015 (SCI-Expanded, Scopus)
2014
2014156. A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with Non-alcoholic fatty liver disease
Arslan M. S., Turhan S., Dinçer İ., Mizrak D., Çorapçıoğlu D., İdilman R.
DIABETOLOGY & METABOLIC SYNDROME
, cilt.6, 2014 (SCI-Expanded, Scopus)
2014
2014157. Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis delta
Kabacam G., Wedemeyer H., SAVAŞ B., Keskin O., Dalekos G., TABAK Ö. F., et al.
LIVER INTERNATIONAL
, cilt.34, sa.8, ss.1207-1215, 2014 (SCI-Expanded, Scopus)
2014
2014158. Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: Performance of phylogenetic analysis of the NS5B, E1, and 5 ' UTR regions in genotyping efficiency
Alagoz G. K., Karatayli S. C., Karatayli E., Celik E., Keskin O., Dinc B., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.25, sa.4, ss.405-410, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
2014159. Public awareness of hepatitis B infection in Turkey as a model of universal effectiveness in health care policy
Gurakar M., Malik M., Keskin O., İDİLMAN R.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.25, sa.3, ss.304-308, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
2014160. Strategies to manage hepatitis C virus (HCV) disease burden
Wedemeyer H., Duberg A. S., Buti M., Rosenberg W. M., Frankova S., Esmat G., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.21, ss.60-89, 2014 (SCI-Expanded, Scopus)
2014
2014161. A one step real time PCR method for the quantification of hepatitis delta virus RNA using an external armored RNA standard and intrinsic internal control
Karatayli E., Altunoglu Y. C., Karatayli S. C., Alagoz S. G. K., ÇINAR K., YALÇIN K., et al.
JOURNAL OF CLINICAL VIROLOGY
, cilt.60, sa.1, ss.11-15, 2014 (SCI-Expanded, Scopus)
2014
2014162. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease
Idilman I. S., Keskin O., ELHAN A. H., Idilman R., KARÇAALTINCABA M.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
, cilt.49, sa.5, ss.617-624, 2014 (SCI-Expanded, Scopus)
2014
2014163. Historical epidemiology of hepatitis C virus (HCV) in selected countries
Bruggmann P., Berg T., Ovrehus A. L. H., Moreno C., Brandao Mello C. E., Roudot-Thoraval F., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.21, ss.5-33, 2014 (SCI-Expanded, Scopus)
2014
2014164. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
Razavi H., Waked I., Sarrazin C., Myers R. P., Idilman R., Calinas F., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.21, ss.34-59, 2014 (SCI-Expanded, Scopus)
2014
2014165. Tumour necrosis factor-alpha, interleukin-10, interferon-gamma and vitamin D receptor gene polymorphisms in patients with chronic hepatitis delta
Karatayli S. C., Ulger Z. E., Ergul A. A., Keskin O., Karatayli E., Albayrak R., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.21, sa.4, ss.297-304, 2014 (SCI-Expanded, Scopus)
2014
2014166. Endoscopic treatment of biliary complications following liver transplantation
Seven G., ÇINAR K., İDİLMAN R., TÜZÜNER A., Hazinedaroglu S. M., Karayalcin S., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.25, sa.2, ss.156-161, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
2014167. Manometric assessment of esophageal motor function in patients with primary biliary cirrhosis
Bektas M., Seven G., İDİLMAN R., Yakut M., DOĞANAY ERDOĞAN B., Kabacam G., et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE
, cilt.25, sa.3, ss.230-234, 2014 (SCI-Expanded, Scopus)
2014
2014168. Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B
Keskin O., Ormeci A. C., Baran B., Kabacam G., Tuzun A., Karatayli E., et al.
ANTIVIRAL THERAPY
, cilt.19, sa.6, ss.543-550, 2014 (SCI-Expanded, Scopus)
2013
2013169. Vanishing bile duct syndrome after allogeneic bone marrow transplantation: Is it the end of the road?
Bakanay S. M., Ugur Bilgin A., Bektas M., İDİLMAN R., Erden E., Arat M., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.24, sa.4, ss.359-362, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
2013170. Hepatic Steatosis: Quantification by Proton Density Fat Fraction with MR Imaging versus Liver Biopsy
İDİLMAN İ. S., Aniktar H., İDİLMAN R., Kabacam G., SAVAŞ B., ELHAN A. H., et al.
RADIOLOGY
, cilt.267, sa.3, ss.767-775, 2013 (SCI-Expanded, Scopus)
2013
2013171. Kidney transplantation from hepatitis B (HB)-positive donors to HB negative recipients: anti-HB Core immunoglobulin G became positive in all recipients after the transplantation.
Celebi Z. K., Sengul Ş., Soypacaci Z., Yayar O., Idilman R., Tuzuner A., et al.
Transplantation proceedings
, cilt.45, sa.3, ss.923-5, 2013 (SCI-Expanded, Scopus)
2013
2013172. Clonal analysis of the quasispecies of antiviralresistant HBV genomes in patients with entecavir resistance during rescue treatment and successful treatment of entecavir resistance with tenofovir
Karatayli E., İDİLMAN R., Karatayli S. C., Cevik E., Yakut M., Seven G., et al.
Antiviral Therapy
, cilt.18, sa.1, ss.77-85, 2013 (SCI-Expanded, Scopus)
2013
2013173. Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interactions
Nishimura T., Hu Y., Wu M., Pham E., Suemizu H., Elazar M., et al.
Journal of Pharmacology and Experimental Therapeutics
, cilt.344, sa.2, ss.388-396, 2013 (SCI-Expanded, Scopus)
2012
2012174. HBeAg-positive hepatitis delta: Virological patterns and clinical long-term outcome
Heidrich B., C. Serrano B., İDİLMAN R., Kabaçam G., Bremer B., Raupach R., et al.
Liver International
, cilt.32, sa.9, ss.1415-1425, 2012 (SCI-Expanded, Scopus)
2012
2012175. The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country
Toy M., ÖNDER F. O., İDİLMAN R., Kabacam G., Richardus J. H., Bozdayi M., et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS
, cilt.13, sa.5, ss.663-676, 2012 (SSCI, Scopus)
2012
2012176. Entecavir treatment of chronic hepatitis D
Kabaçam G., Önder F. O., Yakut M., Seven G., Karatayli S. C., Karatayli E., et al.
Clinical Infectious Diseases
, cilt.55, sa.5, ss.645-650, 2012 (SCI-Expanded, Scopus)
2012
2012177. Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients
Idilman R., Cinar K., Seven G., Bozkus Y., ELHAN A. H., Bozdayi M., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.19, sa.3, ss.220-226, 2012 (SCI-Expanded, Scopus)
2012
2012178. Potential proteomic biomarkers in assessing liver fibrosis using SELDI-TOF MS
Karatayli S. C., Alagöz S. G., Mizrak D., Sayki M., Özkan M., SAVAŞ B., et al.
Turkish Journal of Gastroenterology
, cilt.23, sa.1, ss.46-53, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
2012179. Molecular characterization of a novel entecavir mutation pattern isolated from a multi-drug refractory patient with chronic hepatitis B infection
Karatayli E., Karatayli S. C., ÇINAR K., GÖKAHMETOĞLU S., GÜVEN K., İDİLMAN R., et al.
Journal of Clinical Virology
, cilt.53, sa.2, ss.130-134, 2012 (SCI-Expanded, Scopus)
2012
2012180. Hepatic encephalopathy
Yurdaydin C., İDİLMAN R.
European Gastroenterology and Hepatology Review
, cilt.7, sa.4, ss.268-271, 2012 (Scopus)
2011
2011181. Complete genome sequences and phylogenetic analysis of hepatitis delta viruses isolated from nine Turkish patients
Çelik I., Karatayli E., Çevik E., Gökçe Kabakçi S., Karatayli S. C., Dinç B., et al.
Archives of Virology
, cilt.156, sa.12, ss.2215-2220, 2011 (SCI-Expanded, Scopus)
2011
2011182. Assessment of Helicobacter pylori eradication rate of triple combination therapy containing levofloxacin
Seven G., ÇINAR K., Yakut M., İDİLMAN R., Özden A.
Turkish Journal of Gastroenterology
, cilt.22, sa.6, ss.582-586, 2011 (SCI-Expanded, Scopus, TRDizin)
2011
2011183. Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: Before and after transplantation
İDİLMAN R., Arat M.
Expert Review of Anti-Infective Therapy
, cilt.9, sa.8, ss.641-652, 2011 (SCI-Expanded, Scopus)
2011
2011184. Gamma-glutamyltranspeptidase in predicting sustained virological response in individuals with chronic hepatitis C
Çoban Ş., İDİLMAN R., Erden E., Tuz̈un̈ A.
Hepato-Gastroenterology
, cilt.58, sa.109, ss.1301-1306, 2011 (SCI-Expanded, Scopus)
2011
2011185. Lymphoproliferative Disorders in Individuals With Chronic Hepatitis B and C in the Turkish Population
İDİLMAN R., Bozkus Y., CENGİZ SEVAL G., Mizrak D., ÇINAR K., Ustun Y., et al.
JOURNAL OF MEDICAL VIROLOGY
, cilt.83, sa.6, ss.974-980, 2011 (SCI-Expanded, Scopus)
2010
2010186. Natural history and treatment of chronic delta hepatitis.
Yurdaydin C., Idilman R., Bozkaya H., Bozdayi A.
Journal of viral hepatitis
, cilt.17, sa.11, ss.749-56, 2010 (SCI-Expanded, Scopus)
2010
2010187. MR angiography of esophageal mural veins in portal hypertension: a correlation with endoscopic grades of esophageal varices.
Erden A., İDİLMAN R., Erden I., Bektaş M., Özden A.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.21, sa.3, ss.275-9, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
2010188. The Characteristics and Clinical Outcome of Drug-induced Liver Injury A Single-center Experience
İDİLMAN R., Bektas M., Cinar K., TÖRÜNER M., Cerit E. T., DOĞANAY ERDOĞAN B., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY
, cilt.44, sa.6, 2010 (SCI-Expanded, Scopus)
2010
2010189. Endoscopic management of biliary parasitic diseases
Bektaş M., Dökmeci A., ÇINAR K., Halici I., Oztas E., Karayalcin S., et al.
Digestive Diseases and Sciences
, cilt.55, sa.5, ss.1472-1478, 2010 (SCI-Expanded, Scopus)
2010
2010190. Gastric aberrant pancreas
Mizrak D., Bektaş M., KAYGUSUZ G., ÇINAR K., İDİLMAN R., Özden A.
Turkish Journal of Gastroenterology
, cilt.21, sa.1, ss.68-69, 2010 (SCI-Expanded, Scopus, TRDizin)
2009
2009191. Aflatoxin exposure in viral hepatitis patients in Turkey
Mizrak D., Engin B., ÖNDER F. O., Yener B., Bektas M., Biyikli Z., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.20, sa.3, ss.192-197, 2009 (SCI-Expanded, Scopus, TRDizin)
2009
2009192. A short course of add-on adefovir dipivoxil treatment in lamivudine-resistant chronic hepatitis B patients
İDİLMAN R., Kaymakoglu S., Oguz Onder F., Ahishali E., Bektas M., ÇINAR K., et al.
Journal of Viral Hepatitis
, cilt.16, sa.4, ss.279-285, 2009 (SCI-Expanded, Scopus)
2009
2009193. Awareness of the endoscopist affects detection rate of heterotopic gastric mucosa in esophagus
Korkut E., Bektas M., SAVAŞ B., Memmedzade F., Öztas E., Üstün Y., et al.
Indian Journal of Gastroenterology
, cilt.28, sa.2, ss.75-76, 2009 (Scopus)
2009
2009194. Veins around the esophagus and the stomach: Do their calibrations provide a diagnostic clue for portal hypertensive gastropathy?
Erden A., İDİLMAN R., Erden I., Ozden A.
CLINICAL IMAGING
, cilt.33, sa.1, ss.22-24, 2009 (SCI-Expanded, Scopus)
2008
2008195. PPAR-alpha L162V polymorphism in human hepatocellular carcinoma
Koytak E. S., Mizrak D., Bektas M., Verdi H., ARSLAN ERGÜL A., Idilman R., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.19, sa.4, ss.245-249, 2008 (SCI-Expanded, Scopus, TRDizin)
2008
2008196. Hepatic complications of allogeneic hematopoietic cell transplantation
İDİLMAN R., Arat M.
Turkish Journal of Hematology
, cilt.25, sa.3, ss.111-123, 2008 (SCI-Expanded, Scopus, TRDizin)
2008
2008197. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis
Idilman R., Mizrak D., Corapcioglu D., Bektas M., Doganay B., Sayki M., et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
, cilt.28, sa.2, ss.200-208, 2008 (SCI-Expanded, Scopus)
2008
2008198. Adjuvant therapeutic plasma exchange in liver failure - Assessments of clinical and laboratory parameters
Bektas M., İDİLMAN R., Soykan I., Soydan E., Arat M., ÇINAR K., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY
, cilt.42, sa.5, ss.517-521, 2008 (SCI-Expanded, Scopus)
2008
2008199. P wave dispersion is prolonged in patients with Wilson's disease
Arat N., Kacar S., Golbasi Z., Akdogan M., Sokmen Y., Kuran S., et al.
WORLD JOURNAL OF GASTROENTEROLOGY
, cilt.14, sa.8, ss.1252-1256, 2008 (SCI-Expanded, Scopus)
2007
2007200. Hydatid cysts in muscle: a modified percutaneous treatment approach
Ormeci N., Idilman R., Akyar S., Palabiylkoglu M., Coban S., Erdem H., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
, cilt.11, sa.3, ss.204-208, 2007 (SCI-Expanded, Scopus)
2007
2007201. The fate of recipient-derived hepatocytes in sex-mismatched liver allograft following liver transplantation
Idilman R., Erden E., KUZU I., Ersoz S., Karayalcin S.
CLINICAL TRANSPLANTATION
, cilt.21, sa.2, ss.202-206, 2007 (SCI-Expanded, Scopus)
2006
2006202. A case of systemic lupus erythematosus presenting with protein-losing enteropathy
Türkçapar N., ÖZYÜNCÜ N., ÇINAR K., ENSARİ A., KÜÇÜK N. Ö., İDİLMAN R., et al.
Turkish Journal of Gastroenterology
, cilt.17, sa.3, ss.226-230, 2006 (SCI-Expanded, Scopus, TRDizin)
2006
2006203. Antituberculous therapy-induced fulminant hepatic failure: Successful treatment with liver transplantation and nonstandard antituberculous therapy
Idilman R., Ersoz S., Coban S., Kumbasar Z., Bozkaya H.
LIVER TRANSPLANTATION
, cilt.12, sa.9, ss.1427-1430, 2006 (SCI-Expanded, Scopus)
2006
2006204. Duration of lamivudine prophylaxis in inactive hepatitis B virus carriers with haemato/oncological malignancies who receive chemotherapy
Idilman R.
GUT
, cilt.55, sa.8, ss.1208-1209, 2006 (SCI-Expanded, Scopus)
2006
2006205. Hepatitis B core antigen expression pattern reflects the response to anti-viral treatment
Uzun Y., Bozkaya H., Erden E., Cinar K., Idilman R., Yurdaydin C., et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
, cilt.21, sa.6, ss.977-981, 2006 (SCI-Expanded, Scopus)
2006
2006206. Macro-amylasemia in a patient with selective IgA deficiency and antiphospholipid antibodies
Türkçapar N., ÖZYÜNCÜ N., İDİLMAN R., ENSARİ A., Soylu K., Özden A.
Turkish Journal of Gastroenterology
, cilt.17, sa.2, ss.140-143, 2006 (SCI-Expanded, Scopus, TRDizin)
2006
2006207. Anti-viral prophylaxis in inactive hepatitis B virus carriers with hemato-oncological malignancies who receive chemotherapy
İDİLMAN R.
Minerva Gastroenterologica e Dietologica
, cilt.52, sa.1, ss.39-45, 2006 (Scopus)
2006
2006208. Long-term prognosis of nonalcoholic fatty liver disease: Is pharmacological therapy actually necessary?
Cinar K., Coban S., Idilman R., Tuzun A., Sarioglu M., Bektas M., et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
, cilt.21, sa.1, ss.169-173, 2006 (SCI-Expanded, Scopus)
2006
2006209. Evaluation of the effect of transplant-related factors and tissue injury on donor-derived hepatocyte and gastrointestinal epithelial cell repopulation following hematopoietic cell transplantation
Idilman R., KUZU I., Erden E., Arat M., Soydan E., Soykan I., et al.
BONE MARROW TRANSPLANTATION
, cilt.37, sa.2, ss.199-206, 2006 (SCI-Expanded, Scopus)
2005
2005210. Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver
Arat M., Idilman R., Soydan E., Soykan I., Erden E., Karayalcin S., et al.
CLINICAL TRANSPLANTATION
, cilt.19, sa.6, ss.798-803, 2005 (SCI-Expanded, Scopus)
2005
2005211. Intestinal B cell lymphoma associated with chronic hepatitis C and celiac disease
Coban S., Palabiyikoglu M., ENSARİ A., Idilman R., Koklu S., Yolcu O., et al.
DIGESTIVE DISEASES AND SCIENCES
, cilt.50, sa.12, ss.2359-2361, 2005 (SCI-Expanded, Scopus)
2005
2005212. Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosis
Verdi H., Koytak E., Onder O., Cinar K., Idilman R., Erden E., et al.
JOURNAL OF INVESTIGATIVE MEDICINE
, cilt.53, sa.7, ss.353-359, 2005 (SCI-Expanded, Scopus)
2005
2005213. Trefoil factor expression graft-versus-host disease of in biliary epithelium of the liver after allogeneic hematopoietic cell transplantation
Idilman R., Erden E., Arat M., Soydan E., Erkan O., KUZU I., et al.
TRANSPLANTATION
, cilt.80, sa.8, ss.1099-1104, 2005 (SCI-Expanded, Scopus)
2005
2005214. A new percutaneous approach for the treatment of hydatid cyst of the kidney: Long-term follow-up
Ormeci N., Idilman R., Tuzun A., Erdem H., Palabiyikoglu M.
INTERNATIONAL UROLOGY AND NEPHROLOGY
, cilt.37, sa.3, ss.461-464, 2005 (SCI-Expanded, Scopus)
2005
2005215. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection
Bozdayi G., Turkyilmaz A., Idilman R., Karatayli E., Rota S., Yurdaydin C., et al.
JOURNAL OF MEDICAL VIROLOGY
, cilt.76, sa.4, ss.476-481, 2005 (SCI-Expanded, Scopus)
2005
2005216. Lamivudine prophylaxis in HBV carriers with haemato-oncological malignancies who receive chemotherapy
Idilman R.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
, cilt.55, sa.6, ss.828-831, 2005 (SCI-Expanded, Scopus)
2005
2005217. An unusual presentation of helicobacter pylori infection: So-called "Russell body gastritis"
ENSARİ A., Savas B., Heper A., KUZU I., Idilman R.
Virchows Archiv
, cilt.446, sa.4, ss.463-466, 2005 (SCI-Expanded, Scopus)
2005
2005218. Sexual dysfunctions in HCV patients and its correlations with psychological and biological variables
Soykan A., Boztas H., Idilman R., Ozel E. T., Tuzun A., Ozden A., et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
, cilt.17, sa.2, ss.175-179, 2005 (SCI-Expanded, Scopus)
2005
2005219. Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemia
Bozkaya H., Yurdaydin C., Idilman R., Tuzun A., Cinar K., Erkan O., et al.
ANTIVIRAL THERAPY
, cilt.10, sa.2, ss.319-325, 2005 (SCI-Expanded, Scopus)
2004
2004220. Recipient-derived hepatocytes in sex-mismatched liver allografts after liver transplantation: Early versus late transplant biopsies
Idilman R., Erden E., KUZU I., Ersoz S., KARASU A. Z., Karayalcin K., et al.
TRANSPLANTATION
, cilt.78, sa.11, ss.1647-1652, 2004 (SCI-Expanded, Scopus)
2004
2004221. Lymphoproliferative disorders in chronic hepatitis C
Idilman R., Colantoni A., De Maria N., Alkan S., Nand S., Van Thiel D.
JOURNAL OF VIRAL HEPATITIS
, cilt.11, sa.4, ss.302-309, 2004 (SCI-Expanded, Scopus)
2004
2004222. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies
Idilman R., Arat M., Soydan E., TÖRÜNER M., Soykan I., Akbulut H., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.11, sa.2, ss.141-147, 2004 (SCI-Expanded, Scopus)
2003
2003223. Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation.
Idilman R., Ustun C., Karayaicin S., Aktemel A., Turkyilmaz A., Ozcan M., et al.
Clinical transplantation
, cilt.17, sa.5, ss.438-43, 2003 (SCI-Expanded, Scopus)
2003
2003224. Hepatic apoptosis and proliferation in male and female rats fed alcohol: role of cytokines
Colantoni A., Idilman R., De Maria N., La Paglia N., Belmonte J., Wezeman F., et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
, cilt.27, sa.7, ss.1184-1189, 2003 (SCI-Expanded, Scopus)
2003
2003225. Reversal of iron deficiency anemia in a patient with gastric antral vascular ectasia treated with cyproheptadine
Soykan I., TÖRÜNER M., Idilman R., Ozden A.
JOURNAL OF CLINICAL GASTROENTEROLOGY
, cilt.36, sa.2, ss.183-184, 2003 (SCI-Expanded, Scopus)
2003
2003226. Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals
Idilman R., Colantoni A., De Maria N., Ustun C., Sam R., Ing T., et al.
HEPATO-GASTROENTEROLOGY
, cilt.50, sa.49, ss.217-221, 2003 (SCI-Expanded, Scopus)
2002
2002227. A new therapeutic approach for treatment of hydatid cysts of the spleen
Ormeci N., Soykan I., Palabiyikoglu M., Idilman R., Erdem H., Bektas A., et al.
DIGESTIVE DISEASES AND SCIENCES
, cilt.47, sa.9, ss.2037-2044, 2002 (SCI-Expanded, Scopus)
2002
2002228. Is pain experienced during liver biopsy an important factor?
Soykan I., TÖRÜNER M., Sarioglu M., Idilman R.
JOURNAL OF CLINICAL GASTROENTEROLOGY
, cilt.35, sa.1, ss.102-103, 2002 (SCI-Expanded, Scopus)
2002
2002229. Impaired response to high-dose interferon treatment in African-Americans with chronic hepatitis C.
De Maria N., Colantoni A., Idilman R., Friedlander L., Harig J., Van Thiel D. H.
Hepato-gastroenterology
, cilt.49, sa.45, ss.788-92, 2002 (SCI-Expanded, Scopus)
2002
2002230. Estrogen status and response to combination therapy for chronic hepatitis C
De Maria N., Colantoni A., Idilman R., Leone N., Villa E., Van Thiel D.
JOURNAL OF HEPATOLOGY
, cilt.36, ss.233, 2002 (SCI-Expanded, Scopus)
2002
2002231. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C
Idilman R., De Maria N., Colantoni A., Nadir A., Van Thiel D.
AMERICAN JOURNAL OF GASTROENTEROLOGY
, cilt.97, sa.2, ss.435-439, 2002 (SCI-Expanded, Scopus)
2002
2002232. Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C
Idilman R., Cetinkaya H., Savas I., Aslan N., SAK S., Bastemir M., et al.
JOURNAL OF MEDICAL VIROLOGY
, cilt.66, sa.1, ss.34-39, 2002 (SCI-Expanded, Scopus)
2002
2002233. Liver transplantation for fulminant hepatic failure
Van Thiel D., Brems J., Nadir A., Idilman R., Colantoni A., Holt D., et al.
JOURNAL OF GASTROENTEROLOGY
, cilt.37, ss.78-81, 2002 (SCI-Expanded, Scopus)
2001
2001234. Repopulation of liver endothelial cells, but not hepatocytes, by allogeneic hematopoietic cell transplants.
Idilman R., Tukun A., Erdem E., Arat M., TÖRÜNER M., Soykan I., et al.
BLOOD
, cilt.98, sa.11, 2001 (SCI-Expanded, Scopus)
2001
2001235. B-cell lymphoproliferative and plasma cell disorders in individuals with chronic hepatitis C.
Idilman R., Colantoni A., De Maria N., Alkan S., Nand S., Soykan I., et al.
HEPATOLOGY
, cilt.34, sa.4, 2001 (SCI-Expanded, Scopus)
2001
2001236. Increased effective immunogenicity to high-dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosis
De Maria N., Idilman R., Colantoni A., Van Thiel D.
JOURNAL OF VIRAL HEPATITIS
, cilt.8, sa.5, ss.372-376, 2001 (SCI-Expanded, Scopus)
2001
2001237. Effect of human immunodeficiency virus on the outcome of hepatitis C virus infection
Idilman R., Colantoni A., De Maria N.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
, cilt.36, sa.3, ss.225-234, 2001 (SCI-Expanded, Scopus)
2001
2001238. Evidence of oxidative injury during aging of the liver in a mouse model.
Colantoni A., Idilman R., de Maria N., Duffner L., Van Thiel D., Witte P., et al.
JOURNAL OF THE AMERICAN AGING ASSOCIATION
, cilt.24, sa.2, ss.51-57, 2001 (SCI-Expanded, Scopus)
2000
2000239. The impact of previous HBV infection on the course of chronic hepatitis C
De Maria N., Colantoni A., Friedlander L., Leandro G., Idilman R., Harig J., et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY
, cilt.95, sa.12, ss.3529-3536, 2000 (SCI-Expanded, Scopus)
2000
2000240. Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation: Risk and benefit ratio of HBV vaccination in recipients.
Idilman R., Ustun C., Akan H., Karayalcin S., Ozcan M., Arslan O., et al.
HEPATOLOGY
, cilt.32, sa.4, 2000 (SCI-Expanded, Scopus)
2000
2000241. Influence of sex hormonal status on alcohol-induced oxidative injury in male and female rat liver.
Colantoni A., La Paglia N., De Maria N., Emanuele M. A., Emanuele N. V., Idilman R., et al.
Alcoholism, clinical and experimental research
, cilt.24, sa.9, ss.1467-73, 2000 (SCI-Expanded, Scopus)
2000
2000242. Antibody response to hepatitis B virus vaccination in individuals with hepatitis C virus infection
De Maria N., Idilman R., Colantoni A., Harig J., Van Thiel D.
HEPATOLOGY
, cilt.32, sa.2, ss.444, 2000 (SCI-Expanded, Scopus)
2000
2000243. Cirrhosis in Turner's syndrome: Case report and literature review
Idilman R., De Maria N., Colantoni A., Kugelmas M., Van Thiel D.
European Journal of Gastroenterology and Hepatology
, cilt.12, sa.6, ss.707-709, 2000 (SCI-Expanded, Scopus)
2000
2000244. The incidence of Hepatitis G virus in patients with hematological malignancies: The relationship to the number of blood and blood products transfusions
İDİLMAN R., Ustun C., Aslan O., ÖZCAN M. E., Arat M., Bozkaya H., et al.
Turkish Journal of Haematology
, cilt.17, sa.2, ss.67-71, 2000 (SCI-Expanded, Scopus, TRDizin)
2000
2000245. Immunosuppressive therapy-induced hepatotoxicity in patients with aplastic anemia
Dilek I., İDİLMAN R., Fenkci S., Ustun C., KOÇ H., İLHAN O., et al.
Turkish Journal of Haematology
, cilt.17, sa.3, ss.111-117, 2000 (SCI-Expanded, Scopus, TRDizin)
2000
2000246. The response to interferon plus ribavirin re-treatment for chronic hepatitis C in interferon non-responders is not influenced by race
De Maria N., Colantoni A., Idilman R., Harig J., Van Thiel D.
JOURNAL OF HEPATOLOGY
, cilt.33, sa.6, ss.1028-1029, 2000 (SCI-Expanded, Scopus)
1999
1999247. Adoptive immunity transfer in hepatitis B virus carriers with hematological malignancy who undergoing allogeneic hematopoietic stem cell transplantation
Idilman R., Ustun C., Turkyilmaz A., GÜRMAN G., Ozcan M., Karayalcin S., et al.
HEPATOLOGY
, cilt.30, sa.4, 1999 (SCI-Expanded, Scopus)
1999
1999248. Flow cytometric evaluation of cell counts in bronchoalveolar lavage fluid of patients with hepatitis C virus: As a predictive marker of idiopathic pulmonary fibrosis
Idilman R., Cetinkaya H., Savas I., Aslan N., Sarioglu M., Bozdayi M., et al.
HEPATOLOGY
, cilt.30, sa.4, 1999 (SCI-Expanded, Scopus)
1999
1999249. Hematopoietic stem cell transplantation from non-replicative hepatitis B virus carriers is safe
Ustun C., Idilman R., GÜRMAN G., Ozcan M., Akyol G., Akan H., et al.
JOURNAL OF HEPATOLOGY
, cilt.31, sa.2, ss.202-209, 1999 (SCI-Expanded, Scopus)
1999
1999250. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma
BEKSAÇ M., Idilman R.
CANCER
, cilt.85, sa.1, ss.242-243, 1999 (SCI-Expanded, Scopus)
1998
1998251. Is there any correlation between transfusion frequency of blood and blood products and blood-borne hepatitis virus transmission?
Idilman R., Ustun C., Bozkaya H., Bozdayi M., Akan H.
BLOOD
, cilt.92, sa.10, 1998 (SCI-Expanded, Scopus)
1998
1998252. Is there any correlation between transfusion frequency of blood and blood products and hepatitis G virus transmission.
Idilman R., Akan H., Ustun C., Bozkaya H., Bozdayi M., Uzunalimoglu O., et al.
HEPATOLOGY
, cilt.28, sa.4, 1998 (SCI-Expanded, Scopus)
1998
1998253. Which hematopoietic stem cell transplantation type is safe for patients with hepatitis B virus carriers.
Ustun C., Idilman R., Ozcan M., Akan H., Karayalcin S., GÜRMAN G., et al.
HEPATOLOGY
, cilt.28, sa.4, 1998 (SCI-Expanded, Scopus)
1998
1998254. Bronchoalveolar lavage fluid findings in patients with hepatitis C virus.
Cetinkava H., Idilman R., Savas I., Bastemir M., Karacan O., Sarioglu M., et al.
HEPATOLOGY
, cilt.28, sa.4, 1998 (SCI-Expanded, Scopus)
1998
1998255. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma
Idilman R., De Maria N., Colantoni A., Van Thiel D.
JOURNAL OF VIRAL HEPATITIS
, cilt.5, sa.5, ss.285-299, 1998 (SCI-Expanded, Scopus)
1998
1998256. Liver transplantation for chronic viral liver disease.
Colantoni A., Hassanein T., Idilman R., Van Thiel D. H.
Hepato-gastroenterology
, cilt.45, sa.23, ss.1357-63, 1998 (SCI-Expanded, Scopus)
1998
1998257. Cladribine therapy in chronic lymphoproliferative disorders: Single center experience
BEKSAÇ M., Ilhan O., Uysal A., Koc H., Idilman R., Arat M., et al.
BRITISH JOURNAL OF HAEMATOLOGY
, cilt.102, sa.1, ss.244, 1998 (SCI-Expanded, Scopus)
1998
1998258. Immunosuppressive drug-induced leukoencephalopathy in patients with liver transplant
Idilman R., De Maria N., Kugelmas M., Colantoni A., Van Thiel D.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.10, sa.5, ss.433-436, 1998 (SCI-Expanded, Scopus)
1998
1998259. Interferon treatment of HCV positive cirrhotic patients.
Idilman R., Colantoni A., De Maria N., Van Thiel D. H.
Hepato-gastroenterology
, cilt.45, sa.20, ss.340-4, 1998 (SCI-Expanded, Scopus)
1998
1998260. Fulminant hepatitis in aplastic anemia: hepatitis G or ALG?
Akan H., Konuk N., Fenkci S., Dilek I., Idilman R., Tuncer S.
BONE MARROW TRANSPLANTATION
, cilt.21, sa.5, ss.533, 1998 (SCI-Expanded, Scopus)
1998
1998261. Current and future therapies for HCV infection: what should the end point for treatment be?
Van Thiel D. H., De Maria N., Colantoni A., Idilman R.
Hepato-gastroenterology
, cilt.45, sa.20, ss.308-20, 1998 (SCI-Expanded, Scopus)
1997
1997262. Donor leukocyte infusions for the treatment of leukemia relapse after allogeneic hematopoietic progenitor cell transplantation.
GÜRMAN G., Arslan O., Koc H., Dilek I., Ustun C., Ozcan M., et al.
BLOOD
, cilt.90, sa.10, ss.4452, 1997 (SCI-Expanded, Scopus)
1997
1997263. Polymerase chain reaction for the detection of HCV-RNA: cryoglobulinaemia as a cause for false negative results.
Colantoni A., De Maria N., Idilman R., Van Thiel D. H.
Italian journal of gastroenterology and hepatology
, cilt.29, sa.3, ss.273-4, 1997 (SCI-Expanded)
1997
1997264. Interferon treatment of cirrhotic patients with chronic hepatitis C
Idilman R., DeMaria N., Colantoni A., Dokmeci A., VanThiel D.
JOURNAL OF VIRAL HEPATITIS
, cilt.4, sa.2, ss.81-91, 1997 (SCI-Expanded, Scopus)
1997
1997265. Successful medical treatment of epithelioid hemangioendothelioma of liver
Idilman R., Dokmeci A., Beyler A., Bastemir M., Ormeci N., Aras N., et al.
ONCOLOGY
, cilt.54, sa.2, ss.171-175, 1997 (SCI-Expanded, Scopus)
1997
1997266. Hepatic osteodystrophy: A review
Idilman R., DeMaria N., Uzunalimoglu O., VanThiel D.
HEPATO-GASTROENTEROLOGY
, cilt.44, sa.14, ss.574-581, 1997 (SCI-Expanded)
1996
1996267. Protein C, protein S and antithrombin III levels in nephrotic syndrome.
Buyukberber S., Aydogdu I., Buyukberber N., Bektas A., Idilman R., Karatan O., et al.
BLOOD
, cilt.88, sa.10, ss.2982, 1996 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2025
20251. A FUNCTIONAL CURE AFTER NUCLEOS(T)IDE ANALOGUE DISCONTINUATION IN NONCIRRHOTIC PATIENTS WITH HBEAGNEGATIVE CHRONIC HEPATITIS B
MELEKOĞLU ELLİK Z., Koç Ö., BODAKÇİ E., GÜMÜŞSOY M., ÖZERCAN A. M., YILMAZ V., et al.
AASLD 2025 congress, 7 - 11 Kasım 2025, (Tam Metin Bildiri)
2025
20252. COMPARISON OF MELD, MELDNA, AND MELD 3.0 SCORING SYSTEMS IN TRANSPLANT PRIORITIZATION IN THE TURKISH POPULATION: A MULTICENTER STUDY
moral k., Harputluoğlu M., ADANIR H., DANIŞ N., KIYICI M., Dayangaç M., et al.
AASLD 2025 congress, 07 Kasım 2025, (Tam Metin Bildiri)
2025
20253. The association of chronic kidney disaese with metabolic syndrome and perirenal adipose tissueliver transplant recipients
HATİPOĞLU S. N., GÖKCAN H., GÜRSOY ÇORUH A., kırkıcı b., MELEKOĞLU ELLİK Z., KOÇ Ö., et al.
AASLD 2025 congress, Washington, Kiribati, 7 - 11 Kasım 2025, (Tam Metin Bildiri)
2024
20244. ASSESSMENT OF THE RELATIONSHIP BETWEEN MRI-BASED INTRAMUSCULAR FAT INDICATING SARCOPENIA IN VARIOUS MUSCLE GROUPS AMONG PATIENTS WITH CHRONIC LIVER DISEASE
Er R. E., Akkaya Z., Ünal S., Kuru Öz D., Çelebi M. M., Gökcan H., et al.
AASLD Kongresi, California, Amerika Birleşik Devletleri, 11 - 15 Kasım 2024, ss.1701-1702, (Özet Bildiri)
2025
20255. NÖROENDOKRİN TÜMÖRDE ATİPİK GÖRÜNÜM: HİPERVASKÜLER OLMAYAN DİFFÜZ İNFİLTRATİF TİP KARACİĞER TUTULUMU
Yalçınkaya A. S., Tüten M. Z., Kuru Öz D., Gülpınar B., Erden G. A., İdilman R.
TÜRK MANYETİK REZONANS DERNEĞİ 29. YILLIK BİLİMSEL TOPLANTISI, Ankara, Türkiye, 1 - 03 Mayıs 2025, ss.78-79, (Özet Bildiri)
2025
20256. Nucleos(t)ide analogue cessation outcomes in non-cirrhotic patients with HBeAg-negative chronic hepatitis B
MELEKOĞLU ELLİK Z., ÜNAL F., Koc O., Duman S., Guvenir S. T., YILMAZ V., et al.
European-Association-for-the-Study-of-the-Liver Congress, Amsterdam, Hollanda, 7 - 10 Mayıs 2025, cilt.82, (Özet Bildiri)
2025
20257. Nucleosid analog cessation outcomes in noncirrhotic patients with HbeAg negative chronic hepatitit B
MELEKOĞLU ELLİK Z., Koç Ö., DUMAN S., GÜVENİR S. T., YILMAZ V., GÜMÜŞSOY M., et al.
EASL congress 2025, 7 - 10 Mayıs 2025, cilt.82, (Özet Bildiri)
2025
20258. Gut metagenomic profiles predict 90-day hospitalizations despite controlling for diet, demographics & cirrhosis details in a multi-country cohort of patients with cirrhosis
Bajaj J., Nikitina D., Sikaroodi M., Alvares-da-Silva M., Torre A., Suk K. T., et al.
European-Association-for-the-Study-of-the-Liver Congress, Amsterdam, Hollanda, 7 - 10 Mayıs 2025, cilt.82, (Özet Bildiri)
2025
20259. Outcomes beyond 10 years in entecavir or tenofovir treated Caucasian chronic hepatitis B patients of the real-life PAGE-B cohort
Papatheodoridis G., Dalekos G., İDİLMAN R., Sypsa V., Buti M., Panero J. L. C., et al.
European-Association-for-the-Study-of-the-Liver Congress, Amsterdam, Hollanda, 7 - 10 Mayıs 2025, cilt.82, (Özet Bildiri)
2025
202510. WIDE VARIATIONS IN ANTIMICROBIAL GENE CARRIAGE IN PATIENTS WITH CIRRHOSIS AND HEALTHY CONTROLS FROM 7 COUNTRIES WITH 1020 PARTICIPANTS: IMPLICATIONS FOR RESISTANT INFECTIONS
Bajaj J. S., Kupcinskas J., Kreivenaite E., Suk K. T., Sharma S., Lee H. W., et al.
Digestive Disease Week, California, Amerika Birleşik Devletleri, 3 - 06 Mayıs 2025, cilt.169, (Özet Bildiri)
2024
202411. HEPATIC STEATOSIS IS ASSOCIATED WITH HBSAG CLEARANCE IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION
BODAKÇİ E., KİREMİTCİ S., DUMAN S., MELEKOĞLU ELLİK Z., GÜMÜŞSOY M., GÜVENİR S. T., et al.
AASLD 2024 congress, 15 - 19 Kasım 2024, (Tam Metin Bildiri)
2024
202412. MAJOR VARIATIONS IN 90-DAY MORTALITY POST-HOSPITAL DISCHARGE AMONG INPATIENTS WITH CIRRHOSIS: A PROSPECTIVE COHORT STUDY FOR THE CLEARED CONSORTIUM
İDİLMAN R., HAKTANIYAN B., Choudhury A. K., Kamath P., Wong F., Alvares-da-Silva M., et al.
The Liver Meeting, California, Amerika Birleşik Devletleri, 15 - 19 Kasım 2024, (Özet Bildiri)
2024
202413. De novo malignancies after liver transplantation: multicenter study a preliminary report
Danis N., Akarsu M., Harputluoglu M., Yilmaz S., Adanir H., Dincer D., et al.
International Congress of the International-Liver-Transplantation-Society (ILTS), Texas, Amerika Birleşik Devletleri, 1 - 04 Mayıs 2024, ss.165-166, (Özet Bildiri)
2024
202414. Histological and clinical disease progression in patients with metabolic associated steatotic liver disease using paired biopsy
ekelik m., TURAN D., GÜMÜŞSOY M., KİREMİTCİ S., BODAKÇİ E., yılmaz V., et al.
EASL congress 2024, 05 Haziran 2024, (Özet Bildiri)
2024
202415. Wide variations in proton pump inhibitor use in hospitalized patients with cirrhosis in a worldwide cohort shows little impact on clinically significant outcomes
Bajaj J., Kamath P. S., Xie Q., Topazian M., Hayes P., Torre A., et al.
European-Association-for-the-Study-of-the-Liver Congress (EASL), Milan, İtalya, 5 - 08 Haziran 2024, (Özet Bildiri)
2024
202416. The impact of tumor budding in patients with hepatocelular carcinoma
Duran o. f., GÖKCAN H., KİREMİTCİ S., YILMAZ V., ÇİFTÇİ A., BODAKÇİ E., et al.
EASL congress 2024, 05 Haziran 2024, (Özet Bildiri)
2024
202417. Requrrence of primary sclerosing cholangitis after living donor liver transplantation: experience from turkish registery
ADALI G., harputluoğlu m., AKDOĞAN KAYHAN M., TURAN D., AKARSU M., DANIŞ N., et al.
EASL congress 2024, 05 Haziran 2024, (Özet Bildiri)
2024
202418. KARACİĞER MRG BULGULARI İLE PRİMER HEPATİK AMİLOİDOZ OLGUSU
Can O., Kuru Öz D., Eskalen Z., Duran A., Yamalı S. C., Bodakçı E., et al.
Türk Manyetik Rezonans Derneği 28. Yıllık Bilimsel Toplantısı , Ankara, Türkiye, 16 - 18 Mayıs 2024, ss.216, (Özet Bildiri)
2024
202419. HEPATİK EPİTELOİD ANJİOMYOLİPOM OLGUSU: BT VE MRG BULGULARI
Ergüden R. E., Kuru Öz D., Gülpınar B., Kiremitci S., Tüzüner A., Erden G. A., et al.
Türk Manyetik Rezonans Derneği 28. Yıllık Bilimsel Toplantısı , Ankara, Türkiye, 16 - 18 Mayıs 2024, ss.181-182, (Özet Bildiri)
2024
202420. DISEASE PROGRESSION IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE USING PAIRED LIVER BIOPSY
TURAN GÖKÇE D., Ekelik M. M., Gumussoy M., Kiremitci S., Bodakci E., Yilmaz V., et al.
Digestive Disease Week (DDW), Washington, Kiribati, 18 - 21 Mayıs 2024, cilt.166, (Özet Bildiri)
2024
202421. Assessing Hepatic Steatosis by Magnetic Resonance Imaging in Potential Living Liver Donors
Kuru Öz D., Ellik Z., Gürsoy Çoruh A., Gümüşsoy M., Adıgüzel M., Kiremitci S., et al.
AASLD-TASL Hepatology Connect Meeting 2024, İzmir, Türkiye, 16 - 17 Şubat 2024, ss.1-2, (Özet Bildiri)
2024
202422. C282Y mutation in hemochromatosis: Single center experience
BODAKÇİ E., GÖKCAN H., GÜMÜŞSOY M., GÜVENİR S. T., YILMAZ V., KARAKAYA M. F., et al.
AASLD-TASL hepatology connect meeting 2024, 16 Şubat 2024, (Özet Bildiri)
2024
202423. Hepatic steatosis is associated with HbsAg clearnce in patients with chronic hepatitis B infection
BODAKÇİ E., DUMAN S., KİREMİTCİ S., MELEKOĞLU ELLİK Z., GÜMÜŞSOY M., ER R. E., et al.
AASLD-TASL hepatology connect meeting 2024, 16 Şubat 2024, (Özet Bildiri)
2024
202424. The impact of tumor budding on tumor biology in patients with hepatocellular carcinoma
Duran O. F., GÖKCAN H., KİREMİTCİ S., GÜVENİR S. T., YILMAZ V., BODAKÇİ E., et al.
AASLD-TASL hepatology connect meeting 2024, 16 Şubat 2024, (Özet Bildiri)
2024
202425. Histological and Clinical disease Progression in Patients with Metabolic Dysfuntion associated Steatotic Liver Disease Isinig Paired Biopsy
Ekelik M. M., TURAN D., GÜMÜŞSOY M., KİREMİTCİ S., BODAKÇİ E., YILMAZ V., et al.
AASLD-TASL hepatology connect meeting 2024, 16 Şubat 2024, (Özet Bildiri)
2024
202426. Assesing Hepatic Steatosis by MRI in potential living liver donors
Kuru Öz d., MELEKOĞLU ELLİK Z., GÜRSOY ÇORUH A., GÜMÜŞSOY M., kırımker o. e., GÖKCAN H., et al.
AASLD-TASL hepatology connect meeting 2024, 16 Şubat 2024, (Özet Bildiri)
2024
202427. SAT-519 The impact of tumor budding on tumor biology in patients with hepatocellular carcinoma
DURAN O. F., GÖKCAN H., KİREMİTCİ S., GÜVENİR S. T., YILMAZ V., BODAKÇİ E., et al.
AASLD-TASL hepatology connect meeting, 16 Şubat 2024, (Tam Metin Bildiri)
2023
202328. Case series of C282Y mutation in the HFE gene in Turkey: Single-center experience
BODAKÇİ E., GÖKCAN H., güvener t., YILMAZ V., ER R. E., KARAKAYA M. F., et al.
19. Euroasian Hepatogastroenterology and Surgery, 13 Kasım 2023, (Tam Metin Bildiri)
2023
202329. Familial NAFLD Cirrhosis Case Series
AKARCA H. T., GÖKCAN H., GÜVENİR S. T., YILMAZ V., İDİLMAN R.
19. Euroasian Hepatogastroenterology and Surgery, 13 Kasım 2023, (Tam Metin Bildiri)
2023
202330. LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS DELTA
Bodakçı E., KARAKAYA M. F., KURU ÖZ D., Turan D. G., DUMAN S., MELEKOĞLU ELLİK Z., et al.
aasld 2023, 5 - 08 Kasım 2023, cilt.78, ss.399-400, (Tam Metin Bildiri)
2023
202331. noninvazive fibrosis markers for assesment for liver fibrosis in patients with chronic hepatitis delta
KARAKAYA M. F., KURU ÖZ D., Turan Gökçe D., DUMAN S., Ellik Z. M., GÜMÜŞSOY M., et al.
AASLD 2023 congress, 10 Kasım 2023, (Tam Metin Bildiri)
2023
202332. Noninvazive fibrosis markers for assesment for liver fibrosis in patients with chronic hepatitis delta
KARAKAYA M. F., KURU ÖZ D., Turan D., DUMAN S., MELEKOĞLU ELLİK Z., GÜMÜŞSOY M., et al.
AASLD 2023 congress, Amerika Birleşik Devletleri, 10 Kasım 2023, (Özet Bildiri)
2023
202333. PRIVATE INSURANCE ACCESS IS ASSOCIATED WITH HIGHER LIVER TRANSPLANT LISTING AND TRANSPLANT ACCESS AND LOWER MORTALITY COMPARED TO NATIONAL INSURANCES IN A LARGE MULTINATIONAL COHORT OF INPATIENTS WITH CIRRHOSIS
Bajaj J. S., Wong F., Xie Q., Kamath P. S., Topazian M., Hayes P. C., et al.
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023, (Özet Bildiri)
2023
202334. REGIONAL DIFFERENCES IN ACUTE KIDNEY INJURY PREVALENCE, CLINICAL CHARACTERISTICS AND PATIENT OUTCOMES IN A MULTI-NATIONAL CONSORTIUM OF INPATIENTS WITH CIRRHOSIS
Wong F., George J., Hayes P. C., Torre A., Kamath P. S., Xie Q., et al.
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023, (Özet Bildiri)
2023
202335. NON - INVASIVE FIBROSIS MARKERS FOR ASSESMENT OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS DELTA
BODAKÇİ E., KARAKAYA M. F., KURU ÖZ D., Gokce D., DUMAN S., Ellik Z., et al.
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023, cilt.78, (Özet Bildiri)
2023
202336. A STUDY OF ACUTE LIVER INJURY ASSOCIATED WITH ORNIDAZOLE: ANALYSIS OF 82 CASES IN TURKIYE
TURAN İ., DURMAZER E. N., Vatansever S., Caliskan A. R., Harputluoglu M., Efe C., et al.
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023, (Özet Bildiri)
2023
202337. GLOBAL PREVALENCE OF INFECTIONS AND IMPACT OF REGIONAL VARIATIONS ON OUTCOMES: MULTI-NATIONAL CONSORTIUM OF CIRRHOSIS STUDY
Xie Q., Cao Z., Choudhury A. K., Kamath P. S., Topazian M., Hayes P. C., et al.
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023, (Özet Bildiri)
2023
202338. ALCOHOL-RELATED ETIOLOGY IS AN INDEPENDENT PREDICTOR OF INPATIENT MORTALITY IN PATIENTS WITH CIRRHOSIS IN A PROSPECTIVE GLOBAL CONSORTIUM
Choudhury A. K., Wong F., Xie Q., Kamath P. S., Topazian M., Hayes P. C., et al.
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023, (Özet Bildiri)
2023
202339. development of Metabolic Disorders in Transplant Recepients
Erdemir G., GÖKCAN H., Gürsoy Çoruh A., GÜLPINAR B., MELEKOĞLU ELLİK Z., GÜMÜŞSOY M., et al.
EASL Congress 21-24 June 2023, Avusturya, 21 - 24 Haziran 2023, cilt.78, ss.477-478, (Tam Metin Bildiri)
2023
202340. development of Metabolik disorders in Liver transplant recepients
Erdemir G., GÖKCAN H., İDİLMAN R.
The 2023 International congress of ILTS ELITA and LICAGE, 03 Mayıs 2023, (Tam Metin Bildiri)
2023
202341. A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.
DUMAN S., KURU ÖZ D., GÜMÜŞSOY M., KİREMİTCİ S., GÖKCAN H., ÖZERCAN A. M., et al.
AASLD-TASL hepatology connect meeting, 28 - 29 Nisan 2023, (Tam Metin Bildiri)
2023
202342. Development of Metabolic Disorders in Transplant Recepients
erdemir g., GÖKCAN H., GÜRSOY ÇORUH A., GÜMÜŞSOY M., DUMAN S., İDİLMAN R.
AASLD-TASL hepatology connect meeting, 28 - 29 Nisan 2023, (Tam Metin Bildiri)
2023
202343. effect of prognostic tests on disease outcome of alcohol-related liver disease
zengin b. a., GÜMÜŞSOY M., DUMAN S., BODAKÇİ E., ÖZERCAN A. M., ER R. E., et al.
AASLD-TASL hepatology connect meeting, 28 Nisan 2023, (Tam Metin Bildiri)
2023
202344. A case of AFP producing cholangiocarcinoma
BODAKÇİ E., GÜMÜŞSOY M., GÜVENİR S. T., KARAKAYA F., GÖKCAN H., İDİLMAN R.
AASLD-TASL hepatology connect meeting, 28 - 29 Nisan 2023, (Tam Metin Bildiri)
2023
202345. Natural Disease outcome in patients with NAFLDÇ a study with paired liver biopsies
GÜMÜŞSOY M., TURAN D., ekelik m., KİREMİTCİ S., DUMAN S., GÜVENİR S. T., et al.
AASLD-TASL hepatology connect meeting, 28 Nisan 2023, (Tam Metin Bildiri)
2023
202346. İdentification of risk factors for alcohol relapse in liver transplant patients with alcohol- related liver disease.
TURAN D., GÜNŞAR F., harputluoğlu m., KABAÇAM G., GÖKCAN H., AKARSU M., et al.
EASL Congress 21-24 June 2023, 21 Nisan 2023, (Tam Metin Bildiri)
2023
202347. A Combination Of Non-Invasive Tests In Detection Of NAFLD-Related Advanced Fibrosis Is Not Superior To MRE Alone
Duman S., Gümüşsoy M., Kuru D., Kiremitci S., Gökcan H., Bodakçı E., et al.
39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber, Bochum, Almanya, 27 - 28 Ocak 2023, cilt.61, ss.30, (Özet Bildiri)
2022
202248. MEFIB AND MAST SCORES ASSESSMENT OF INCIDENT LIVER-RELATED OUTCOMES IN NONALCOHOLIC FATTY LIVER DISEASE: AN INDIVIDUAL PATIENT META-ANALYSIS
Noureddin N., Ajmera V., Bergstrom J., Huang D., Siddiqi H., Majzoub A. M., et al.
American Association for the Study of Liver Diseases, The Liver Meeting (AASLD 2022), Amerika Birleşik Devletleri, 4 - 08 Kasım 2022, (Özet Bildiri)
2022
202249. Alkol Dışı Yağlı Karaciğer Hastalığı Doğal Seyri: Ardışık İkili Karaciğer Biyopsilerinin Karşılaştırılması
GÜMÜŞSOY M., TURAN D., EKELİK M., KİREMİTCİ S., BODAKÇİ E., DUMAN S., et al.
39. ULUSAL GASTROENTEROLOJİ HAFTASI, Antalya, Türkiye, 22 Kasım 2022, (Özet Bildiri)
2022
202250. Alkole Bağlı Karaciğer Hastalığında Prognostik Non-İnvasif Testlerin Hastalık Sonucunu Öngörmede Etkinliği
ZENGİN B. A., GÜMÜŞSOY M., DUMAN S., BODAKÇİ E., GÜVENİR S. T., MELEKOĞLU ELLİK Z., et al.
39. ULUSAL GASTROENTEROLOJİ HAFTASI, Antalya, Türkiye, 22 Kasım 2022, (Özet Bildiri)
2022
202251. Effect of prognostic noninvasive tests on disease outcome of alcohol related liver disease
zengin a., GÜMÜŞSOY M., DUMAN S., BODAKÇİ E., GÜVENİR S. T., MELEKOĞLU ELLİK Z., et al.
aasld 2022, 04 Kasım 2022, (Özet Bildiri)
2022
202252. Natural disease Outcome in patients with NAFLD: A study with paired liver biopsy
GÜMÜŞSOY M., Turan Gökçe D., KİREMİTCİ S., BODAKÇİ E., DUMAN S., MELEKOĞLU ELLİK Z., et al.
aasld 2022, 04 Kasım 2022, (Özet Bildiri)
2022
202253. Metabolic Syndrome in liver Transplant recipient
KARA G., GÖKCAN H., İDİLMAN R.
AASLD 2022, 4 - 08 Kasım 2022, (Özet Bildiri)
2022
202254. Trends and causes of etiology in adult liver transplant patients: multicenter study
AKARSU M., Harputluoğlu M., YILMAZ S., GENÇDAL G., AKYILDIZ M., DİNÇER D., et al.
ınternational Liver congress ILC 2022 (EASL), 22 - 26 Haziran 2022, (Özet Bildiri)
2022
202255. Preliminary Results of The effectiveness and safety of Tenofovir alafenamide Fumarate Prophylaxis in HBV individuals, who received Chemo/Immunsupression therapy
GÜNDÜZ F. F., DURAK S., ÜNSAL Y., DEMİR M., MELEKOĞLU ELLİK Z., YILDIRIM A. E., et al.
ınternational Liver congress ILC 2022 (EASL), 22 Haziran 2022, (Özet Bildiri)
2022
202256. Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patients with hepatitis B virus related cirrhosis
YAPALI S., GÖKCAN H., DURAK S., MELEKOĞLU ELLİK Z., ADANIR H., GÜNDÜZ F. F., et al.
ınternational Liver congress ILC 2022 (EASL), 22 - 26 Haziran 2022, (Özet Bildiri)
2022
202257. Effectiveness of MRI methods in the asssement of hepatic steatosis in living liver donors
KURU ÖZ D., MELEKOĞLU ELLİK Z., GÜRSOY ÇORUH A., GÜMÜŞSOY M., DUMANLI S., ER R. E., et al.
ınternational Liver congress ILC 2022 (EASL), 22 Haziran 2022, (Özet Bildiri)
2022
202258. Real life efficacy and tolerability of Tenofovir alafenamide fumarate in liver transplant recipients: a multicenter study (SAT416)
GÖKCAN H., YAPALI S., HARPUTLUOĞLU M. M. M., MELEKOĞLU ELLİK Z., GÖKÇEN P., ADANIR H., et al.
EASL The International Liver Congress, London, Kanada, 26 Haziran 2022, (Özet Bildiri)
2022
202259. Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis (SAT421)
YAPALI S., GÖKCAN H., DURAK S., MELEKOĞLU ELLİK Z., GÜZELBULUT F., VATANSEVER S., et al.
EASL The International Liver Congress, London, Kanada, 22 Haziran 2022, (Özet Bildiri)
2022
202260. Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in liver transplant recipients: A multicenter study
YAPALI S., GÖKCAN H., MELEKOĞLU ELLİK Z., GÖKÇEN P., ADANIR H., DURAK S., et al.
ILTS 2022, 04 Mayıs 2022, (Özet Bildiri)
2022
202261. Real life efficacy and tolerability of tenofovir alafenamde fumarate in liver transplant recipients: A multicenter study
YAPALI S., GÖKCAN H., harputluoğlu M., MELEKOĞLU ELLİK Z., GÖKÇEN P., ADANIR H., et al.
AASLD TASL Digital Hepatology Meeting, Türkiye, 14 - 15 Ocak 2022, cilt.3, ss.4, (Tam Metin Bildiri)
2022
202262. Biliary complications and management in liver transplant recipients with duct to duct anastomosis: A single center experience
KARAKAYA M. F., ÇINAR K., ER R. E., KIRIMKER E. O., BALCI D., ÖZERCAN A. M., et al.
AASLD-TASL Digital Hepatology Meeting, 14 Ocak 2022, (Özet Bildiri)
2022
202263. Bliary Complications and Management in Liver Transplant Patients with Duct to Duct Anastomotis: Single Center Experience
KARAKAYA M. F., ÇINAR K., ER R. E., KIRIMKER E. O., BALCI D., ÖZERCAN A. M., et al.
AASLD-TASL digital Hepatology Connect, 14 Ocak 2022, (Özet Bildiri)
2022
202264. Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patiernts with hepatitis B virus related cirrhosis
YAPALI S., GÖKCAN H., DURAK S., MELEKOĞLU ELLİK Z., VATANSEVER S., ADANIR H., et al.
AASLD-TASL digital Hepatology Connect, 14 Nisan 2022, (Özet Bildiri)
2022
202265. Efficacy and Safety of Tenofovir alafenamide in hepatitis B virus infected patients with chronic hemodialsis and renal transplantation: a preliminary result
ADANIR H., ÖZER ETİK D., YILDIRIM A. E., YAPALI S., ARI D., GÖKCAN H., et al.
AASLD-TASL digital Hepatology Connect, 14 Ocak 2022, (Özet Bildiri)
2022
202266. Presentation and outcome of autoimmune hepatitis during pregnancy
örmeci a., DUMAN S., İSTEMİHAN Z., GÖKCAN H., ÇAVUŞ B., ARSLAN K., et al.
AASLD-TASL digital Hepatology Connect, 14 Ocak 2022, (Özet Bildiri)
2022
202267. The Effect of Clinicopathologic findings of Hepatosellüler carcinoma on posttransplant survival: A multicenter kohort from TASL Liver Transplantation special İnterest group
AKYILDIZ M., GENÇDAL G., İNCE V., Harputluoğlu M., ZEYTÜNLÜ M., KILIÇ M., et al.
AASLD-TASL digital Hepatology Connect, 14 - 16 Ocak 2022, (Tam Metin Bildiri)
2022
202268. Development of Metabolic Disorders İn Liver Transplant Patients
KARA G., GÖKCAN H., GÜMÜŞSOY M., DUMAN S., İDİLMAN R.
AASLD-TASL digital Hepatology Connect, 14 Ocak 2022, (Özet Bildiri)
2022
202269. Trends and changes of etiology in adult liver transplant patients: mulitcenter study
AKARSU M., Harputluoğlu M., YILMAZ S., AKYILDIZ M., GENÇDAL G., polat k. y., et al.
AASLD-TASL digital Hepatology Connect, 14 Ocak 2022, (Tam Metin Bildiri)
2021
202170. Kemoterapi ve İmmünosüpresif Tedavi Alan Hastalarda Hepatit B Reaktivasyon Profilaksisinde Tenofovir Alafenamid Fumaratın Etkinliği ve Güvenliği: Çok Merkezli-Gözlemsel Çalışmanın ilk Sonuçları
GÜNDÜZ F., DURAK S., ÜNSAL Y., DEMİR M., MELEKOĞLU ELLİK Z., YILDIRIM E., et al.
38. Ulusal Gastroenteroloji Haftası 16-21 Kasım 2021, Antalya, 16 Kasım 2021, (Özet Bildiri)
2021
202171. ’Duct to Duct Anastomozlu’ Karaciğer Transplantasyon Hastalarında Biliyer Komplikasyonlar ve Yönetimi: Tek Merkez Deneyimi
KARAKAYA M. F., ÇINAR K., ER R. E., KIRIMKER E. O., BALCI D., ÖZERCAN A. M., et al.
38. ULUSAL GASTROENTEROLOJİ HAFTASI, Antalya, Türkiye, 16 Kasım 2021, (Özet Bildiri)
2021
202172. Real life Efficay and Tolerability of Tenofovir alafanamide fumarate in patients with hepatitis B virus related cirrhosis and liver transplant recepients: a prilimanary result
YAPALI S., GÖKCAN H., Harputluoğlu M., MELEKOĞLU ELLİK Z., AKARSU M., ADANIR H., et al.
AASLD 2021 congress, 05 Kasım 2021, (Özet Bildiri)
2021
202173. Karaciğer Donörlerinin Preoperatif Yağlanma Değerlendirilmesinde MRG Yöntemlerinin Etkinliği
Kuru Öz D., Melekoğlu Ellik Z., Gürsoy Çoruh A., Adıgüzel M., Gümüşsoy M., Duman S., et al.
38. Ulusal Gastroenteroloji Haftası, 2021, Antalya, Türkiye, 16 Ekim - 21 Kasım 2021, ss.160-161, (Özet Bildiri)
2021
202174. Real Life Efficacy and Tolerability of Tenofovir Alafenamide Fumarate in Patients with Hepatitis B Virus-related Cirrhosis and Liver Transplant Recipients. A-Preliminary Result (798)
YAPALI S., GÖKCAN H., HARPUTLUOĞLU M. M. M., MELEKOĞLU ELLİK Z., AKARSU M., DURAK S., et al.
AASLD the Liver Meeting Digital Experience, Amerika Birleşik Devletleri, 12 Kasım 2021, cilt.74, ss.490, (Özet Bildiri)
2021
202175. Efficacy and Safety of TAF in Hepatitis B virus infected patiebts with chronic hemodialiss and renal transplantation: A prelimanry result
ADANIR H., etik d. ö., YILDIRIM A. E., YAPALI S., COŞAR A. M., ARI D., et al.
AASLD 2021 congress, 06 Kasım 2021, (Özet Bildiri)
2021
202176. association. between non-alcoholic fatty liver disease and extrahepatic malignancy
GÜMÜŞSOY M., İDİLMAN R., GÖKCAN H., BODAKÇİ E., özercan m., ER R. E., et al.
EASL gongress 2021, 23 Haziran 2021, (Özet Bildiri)
2021
202177. Outcome of COVID-19 in Patients with Autoimmune Hepatitis: An International Multi-Centre Study
EFE C., BATIBAY E., DHANASEKARAN R., LAMMERT C., ALOMAN C., MASSOUMİ H., et al.
17. Ulusal Hepato-Gastroenteroloji Kongresi & Middle East & North Africa EUS Club 4th MENA EUS & ERCP Workshop, 17 - 19 Haziran 2021, (Özet Bildiri)
2021
202178. Kemoterapi ve İmmünsüpresif Tedavi Alan Hastalarda Hepatit B Reaktivasyon Profilaksisinde Tenofovir Alafenamide Fumarat’ın Etkinliği ve Güvenirliği: Çok Merkezli-Gözlemsel Çalışmanın İlk Sonuçları
GÜNDÜZ F., ÜNSAL Y., MELEKOĞLU ELLİK Z., MEHDİYEV S., YILDIRIM E., ADANIR H., et al.
13. ULUSAL HEPATOLOJİ KONGRESİ ULUSLARARASI KATILIMLI, 28 - 30 Mayıs 2021, (Özet Bildiri)
2021
202179. EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH CHRONIC HEMODIALYSIS AND KIDNEY TRANSPLANTATION‐ REALITY STUDY
ADANIR H., MELEKOĞLU ELLİK Z., YILDIRIM A. E., GÜNDÜZ F. F., GÖKCAN H., YARAŞ S., et al.
AASLD‐TASL Digital Hepatology Connect Meeting, 2021, 15 Eylül 2021, (Özet Bildiri)
2021
202180. The analysis of liver transplant patients with COVİD-19 infection: a national cohort
KABAÇAM G., TURAN İ., KIYICI M., MELEKOĞLU ELLİK Z., dolu S., Dayangaç M., et al.
AASLD-TASL digital Hepatology Connect, İstanbul, Türkiye, 15 - 16 Ocak 2021, cilt.2, ss.24-25, (Özet Bildiri)
2021
202181. Non-alcoholic fatty liver disease and extrahepatic malignancy
Gümüşsoy M., Turan Gökçe D., Ulaş B. B., Koç Ö., Karataş G., Bodakçı E., et al.
AASLD-TASL digital Hepatology Connect, 15 Ocak 2021, (Tam Metin Bildiri)
2020
202082. MAGNETIC RESONANCE ELASTOGRAPHY AND TRANSIENT ELASTOGRAPGHY TO ASSESS HEPATIC STETAOSIS AND LIVER FIBROSIS IN THE LIVER TRANSPLANT SETTING
Ellik Z., İDİLMAN İ. S., Kartal A. C., Balaban Y. H., KARÇAALTINCABA M., İDİLMAN R.
Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 Kasım 2020, cilt.72, (Özet Bildiri)
2020
202083. AMAP RISK SCORE PREDICTS HEPATOCELLULAR CARCINOMA DEVELOPMENT IN CHRONIC HEPATITIS PATIENTS: AN INTERNATIONAL COHORT COLLABORATION
Fan R., Papatheodoridis G., Sun J., Innes H., Toyoda H., Xie Q., et al.
Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 Kasım 2020, cilt.72, (Özet Bildiri)
2020
202084. Outcomes following deceased and live donor livertransplantation for the indication of acute liver failure: amulticenter experience
TURAN İ., ALADAĞ M., HARPUTLUOĞLU M. M. M., YILMAZ S., GENÇDAL G., POLAT K. Y., et al.
The Digital International Liver Congress (EASL) 2020, 27 - 29 Ağustos 2020, cilt.73, ss.227, (Tam Metin Bildiri)
2020
202085. Diagnostic accuracy of liver stiffness measurement by fibroscan in liver transplant recipients
MELEKOĞLU ELLİK Z., ÇALIŞKAN A., DUMAN S., GÜMÜŞSOY M., ÖZERCAN A. M., ER R. E., et al.
EASL: The Digital International Liver Congress, 27 - 29 Ağustos 2020, cilt.73, ss.528, (Özet Bildiri)
2019
201986. ASSOCIATION BETWEEN NON-ALCOHOLOIC FATTY LIVER DISEASE AND SUBCLINICAL ATHEROSCLEROSIS AND MYOCARDIAL DYSFUNCTION USING MULTIMODALITY IMAGING
ULAŞ B. B., ÖZYÜNCÜ N., ÇALIŞKAN KARTAL A., PEKER E., TURAN GÖKÇE D., GÜMÜŞSOY M., et al.
ANNUAL MEETING OF AASLD / LIVER MEETING, 8 - 12 Kasım 2019, (Tam Metin Bildiri)
2019
201987. NATURAL HISTORY OF INACTIVE HBsAg CARRIERS: A 10-YEAR PROSPECTIVE FOLLOW-UP STUDY
Yurdaydin C., Keskin O., Yurdcu E., Yakut M., Seven G., Kabacam G., et al.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70, (Özet Bildiri)
2019
201988. SIMILAR RISK OF HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT DURING LONG-TERM ENTECAVIR (ETV) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY IN CAUCASIAN CHRONIC HEPATITIS B (CHB) PATIENTS
Papatheodoridis G. V., Dalekos G. N., Yurdaydin C., Sypsa V., van Boemmel F., Buti M., et al.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70, (Özet Bildiri)
2019
201989. TREATMENT DISCONTINUATION IN HBEAG-NEGATIVE CHRONIC HEPATIT B IS A VIABLE OPTION IN NON-CIRRHOTIC GENOTYPE D CHRONIC HEPATITIS B PATIENTS
ŞAH ÜNAL F. T., Keskin O., Yurdcu E., Yilmaz Y., KARAKAYA M. F., Kartal A., et al.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70, (Özet Bildiri)
2019
201990. ASSOCIATION BETWEEN NON-ALCOHOLIC FATTY LIVER DISEASE AND SUBCLINICAL ATHEROSCLEROSIS AND MYOCARDIAL DYSFUNCTION USING MULTIMODALITY IMAGING
Ulas B. B., ÖZYÜNCÜ N., Kartal A. C., PEKER E., Gokce D., Gumussoy M., et al.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70, (Özet Bildiri)
2019
201991. TÜRKİYE’DE HEPATİT C ELİMİNASYONU YOL HARİTASI ÖNERİLERİ VE ÇALIŞTAY RAPORU
AKARCA U. S., AYGEN B., bodur h., GÜNER H. R., İDİLMAN R., KAYMAKOĞLU S., et al.
XI.Ulusal Viral Hepatit Simpozyumu, Türkiye, 14 - 16 Haziran 2019, (Özet Bildiri)
2019
201992. ETIOLOGY OF CIRRHOSIS CHANGING TRENDS OVER THE YEARS: A SINGLE-CENTER TURKISH EXPERIENCE
İDİLMAN R., ÇALIŞKAN KARTAL A., AYDOĞAN M., KARAKAYA M. F., KALKAN Ç., ÖNEM S., et al.
DDW 2019, 19 - 21 Mayıs 2019, (Özet Bildiri)
2019
201993. 10 YILLIK PROSPEKTİF ÇALIŞMADA DÜŞÜK VİRAL YÜKLÜ HBV TAŞIYICILARI REAKTİVASYONDAN ZİYADE HBSAG KAYBETMEYE YATKINDIR.
KESKİN O., YAKUT M., YURDCU E., KALKAN Ç., AGAYEVA S., YILMAZ Y., et al.
12. ULUSAL HEPATOLOJİİ KONGRESİ, Antalya, Türkiye, 1 - 05 Mayıs 2019, (Özet Bildiri)
2019
201994. Plasma metabolomic changes modulate the impact of Middle Eastern versus Western Diet in an international cirrhosis cohort
Cox I. J., İDİLMAN R., Fagan A., Turan D., Ajayi L., Karakaya F., et al.
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Avusturya, 10 - 14 Nisan 2019, cilt.70, (Özet Bildiri)
2019
201995. Prediction of elastographic reversion of cirrhosis after 5 years of entecavir or tenofovir disoproxil fumarate therapy in caucasian chronic hepatitis B patients
Papatheodoridis G., Dalekos G., Yurdaydin C., Sypsa V., van Bommel F., Buti M., et al.
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Avusturya, 10 - 14 Nisan 2019, cilt.70, (Özet Bildiri)
2019
201996. Frequency, severity and impact of Peg-IFNa-associated flares in HDV infection: Results from the HIDIT-II study
Hardtke S., Wedemeyer H., Caruntu F. A., Curescu M., Kendal Y., AKARCA U. S., et al.
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Avusturya, 10 - 14 Nisan 2019, cilt.70, (Özet Bildiri)
2018
201897. Comparison of the efficacy of short term and long term nucleos(t)ide analog treatment in chronic delta hepatitis
YURTAYDIN S. C., KESKİN O., KARAKAYA M. F., YILMAZ Y., ÇALIŞKAN KARTAL A., MELEKOĞLU ELLİK Z., et al.
35. ULUSAL GASTROENTEROLOJİ HAFTASI, Antalya, Türkiye, 21 Kasım 2018, (Özet Bildiri)
2018
201898. Nonnvasve Fbross Scores Are Not Useful for Predcton of Response to Treatment n Chronc Delta Hepatts
KESKİN O., YURDCU E., KALKAN Ç., ÇALIŞKAN KARTAL A., ELLİK Z., BOZDAYI A. M., et al.
AASLD LIVER MEETING 2018, San-Francisco, Kostarika, 9 - 13 Kasım 2018, (Özet Bildiri)
2018
201899. Predicition and need for surveillance of hepatocellular carcinoma (HCC) development after the first 5 years of entecavir or tenofovir disoproxil fumarate therapı in Caucasian chronic hepatitis B patients of the PAGE-B Cohort.
Papatheodoridis G., Dalekos G., YURTAYDIN S. C., Sypsa V., Bommel V., Buti m., et al.
AASLD, 9 - 13 Kasım 2018, (Tam Metin Bildiri)
2018
2018100. Prediction and Need for Surveillance of Hepatocellular Carcinoma (HCC) Development after the First 5 Years of Entecavir (ETV) or Tenofovir Disoproxil Fumarate (TDF) Therapy in Caucasian Chronic Hepatitis B (CHB) Patients of the PAGE-B Cohort
Papatheodoridis G. V., Dalekos G. N., Yurdaydin C., Sypsa V., van Bommel F., Buti M., et al.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68, (Özet Bildiri)
2018
2018101. ALT Levels and Risk of Hepatocellular Carcinoma (HCC) in Caucasian Chronic Hepatitis B (CHB) Patients Under Long-Term Therapy with Entecavir (ETV) or Tenofovir Disoproxil Fumarate (TDF)
Papatheodoridis G. V., Dalekos G. N., Yurdaydin C., Sypsa V., van Bommel F., Buti M., et al.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68, (Özet Bildiri)
2018
2018102. Noninvasive Fibrosis Scores Are Not Useful for Prediction of Response to Treatment in Chronic Delta Hepatitis
Keskin O., Yurdcu E., Kalkan C., Kartal A., Ellik Z., Bozdayi M., et al.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68, (Özet Bildiri)
2018
2018103. Patient Selection and Preparation for Liver Transplantation
İDİLMAN R.
APASL Single Topic Non-Responders, 27 - 29 Eylül 2018, (Tam Metin Bildiri)
2018
2018104. Real world data on safety and efficacy of Ledipasvir Sofosbuvir ± RBV, Ombitasvir / Paritaprevir / Ritonavir ± Dasabuvir ± RBV combination therapy for chronic hepatitis C. A Turkey experience.
DEMİR M., DANIŞ N., KANİ H. T., YILDIRIM A. E., BALKAN A., DEĞERTEKİN M. B., et al.
APASL Single Topic Conference, İstanbul, Türkiye, 27 - 29 Eylül 2018, (Özet Bildiri)
2017
2017105. HEPATİT C ENFEKSİYONUNA BAĞLI DEKOMPANZE SİROZ HASTALARINDA VE KRONİK HEPATİT C ENFEKSİYONU NEDENİYLE KARACİĞER NAKLİ OLANLARDA LEDİPASVİR/SOFOSBUVİR TEDAVİSİNİN ETKİLİLİĞİ: TÜRKİYE ERKEN ERİŞİM PROGRAMI SONUÇLARI
İDİLMAN R., DEMİR M., ALADAĞ M., KAYMAKOĞLU S., EROL C., ÇAVUŞ B., et al.
34. ULUSAL GASTROENTEROLOJİ HAFTASI, Türkiye, 1 - 06 Aralık 2017
2017
2017106. OTOIMMÜN KARACIĞER HASTALIKLARINA EŞLIK EDENEKSTRAHEPATIK OTOIMMÜN HASTALIKLAR VE HASTALIK SEYRI ÜZERINE ETKISI
KARAKAYA M. F., ÖZTEKİN Ş., ÖZTÜRK UÇAR Y., KALKAN Ç., ELHAN A. H., SOYKAN A. İ., et al.
UGH 2017, Türkiye, 1 - 06 Aralık 2017, (Özet Bildiri)
2017
2017107. New therapies for HCV
İDİLMAN R.
16th International Euroasian Congress of Gastroenterology and Surgery, 27 - 30 Nisan 2017, (Özet Bildiri)
2017
2017108. EFFICIACY OF LEDİPASVİR AND SOFOSBUVİR WİTH/WİTHOUT TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE RESULT OF A MULTICENTER TURKISH EARLY ACCES PROGRAM
İDİLMAN R., DEMİR M., ALADAĞ M., KAYMAKOĞLU S., EROL C., ÇAVUŞ B., et al.
VIRAL HEPATITIS (ENDORSED BY AASLD), 3 - 04 Mart 2017
2017
2017109. Efficacy of ledipasvir and sofosbuvir with/without ribavirin for treatment of chronic hepatitis C patients with advanced liver disease results of a multicenter turkish early access program
İDİLMAN R., demir m., ALADAĞ M., KAYMAKOĞLU S., EROL C., cavus b., et al.
Viral Hepatitis, 3 - 04 Mart 2017, (Özet Bildiri)
2017
2017110. Efficacy of ledipasvir and sofosbuvir with/without ribavirin for treatmentof hepatitis C patients Results of a multicenter Turkish Early Access Program
İDİLMAN R., DEMİR M., ALADAĞ M., KAYMAKOĞLU S., CİHAN E., ÇAVUŞ B., et al.
Viral Hepatitis, 3 - 04 Mart 2017, (Özet Bildiri)
2016
2016111. The Role Of Genetic Variability Of PNPLA3 (rs738409) On Predispotion To Non-Alcoholic Fatty Liver Disease In Lean Patients
İDİLMAN R., Karatayli S. C., Karakaya F., Keskin O., Gozukara B., SAVAŞ B., et al.
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64, (Özet Bildiri)
2016
2016112. The risk of hepatocellular carcinoma (HCC) is decreasing after the first 5 years of entecavir (ETV) or tenofovir (TDF) therapy in Caucasian chronic hepatitis B (CHB) patients
Papatheodoridis G. V., Yurdaydin C., Dalekos G. N., Buti M., Chi H., van Boemmel F., et al.
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64, (Özet Bildiri)
2016
2016113. The Prenylation Inhibitor Lonafarnib Can Induce Post-Treatment Alt Flares With Viral Clearance In Patients With Chronic Delta Hepatitis
Yurdaydin C., İDİLMAN R., Kalkan C., Karakaya F., Kartal A. C., Keskin O., et al.
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64, (Özet Bildiri)
2016
2016114. Chronic hepatitis D is a greater risk factor for hepatocellular carcinoma development than chronic hepatitis B
Keskin O., Karakaya F., KaIkon C., Kartal A. C., İDİLMAN R., Yurdaydin C.
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64, (Özet Bildiri)
2016
2016115. Hepatocellular carcinoma (HCC) is the only factor affecting the excellent survival of Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy
Papatheodoridis G. V., Dalekos G. N., Yurdaydin C., van Boemmel F., Buti M., Sypsa V., et al.
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64, (Özet Bildiri)
2016
2016116. Exploring Optimal Dosing Of Lonafarnib With Ritonavir For The Treatment Of Chronic Delta Hepatitis-Interim Results From The Lowr Hdv-2 Study
Yurdaydin C., İDİLMAN R., Kalkan C., Karakaya F., Kartal A. C., Keskin O., et al.
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64, (Özet Bildiri)
2016
2016117. High incidence of significant liver fibrosis among HBeAg-positive patients with low levels of ALT
Sonneveld M. J., Brouwer W. P., Xie Q., Hansen B. E., TABAK Ö. F., İDİLMAN R., et al.
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64, (Özet Bildiri)
2016
2016118. Hepatoselüler Kanserde Tedavi Yaklaşımı
İDİLMAN R.
Hepatoloji Okulu 2016, Türkiye, 13 - 15 Mayıs 2016
2016
2016119. Hepatitis delta virus kinetics under the prenylation inhibitor lonafarnib suggest HDV metiadted suppression of HBV replication
YURTAYDIN S. C., Borochov N., KALKAN Ç., BedRoy S., KARATAYLI E., HaynesWilliams V., et al.
51th Annual Meeting of the European Association for the Study of the Liver (EASL), 13 - 17 Nisan 2016
2015
2015120. Hepatitis B (HBV) Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Lenalidomide Containing Regimens: A Single Center Experience
Ataca P., Atilla E., Kircali E., İDİLMAN R., BEKSAÇ M.
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri)
2015
2015121. Prolongation of interferon therapy increases maintained virological response rates and improves the natural course of chronic delta hepatitis
Keskin O., Tuzun A., Karakaya F., Kalkan C., Kartal A. C., Karatayli E., et al.
66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62, (Özet Bildiri)
2015
2015122. "Normal" Serum ALT/AST Level in Turkish Population
KARASU A. Z., Tozun N., İDİLMAN R., Ozdogan O. C., Kaymakoglu S., Cakaloglu Y., et al.
66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62, (Özet Bildiri)
2015
2015123. Hepatitis C Seropositivity is not as high as Western Countries in the Population Born Between 1945-1965 According to Turkey Nationwide Hepatitis Prevalence Study (TURKHEP 2010)
Ozdogan O. C., Tozun N., Kaymakoglu S., İDİLMAN R., KARASU A. Z., AKARCA U. S.
66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62, (Özet Bildiri)
2015
2015124. Decreasing risk of hepatocellular carcinoma (HCC) development after the first 5 years of entecavir (ETV) or tenofovir (TDF) therapy in Caucasian chronic hepatitis B (CHB) patients
Papatheodoridis G. V., İDİLMAN R., Dalekos G. N., Buti M., Chi H., van Boemmel F., et al.
66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62, (Özet Bildiri)
2015
2015125. Vena caval replacement with cadaveric caval graft for living donor liver transplantation in Budd Chiari syndrome associated with hydatid cyst surgery
BALCI D., KIRIMKER E. O., DURDU M. S., HAZİNEDAROĞLU S. M., MEÇO B. C., ÖZÇELİK M., et al.
ILTS 21st International Congress, 8 - 11 Temmuz 2015
2015
2015126. ultiple Genetic Mutations Increasing Thrombotic Risk Predisposing Both Donor and Recipient Thrombotic Complications After Living Donor Liver Transplantation A Case Report
BALCI D., KIRIMKER E. O., konca c., HAZİNEDAROĞLU S. M., ÖZÇELİK M., MEÇO B. C., et al.
21th ILTS International Congress, 8 - 10 Temmuz 2015, (Tam Metin Bildiri)
2015
2015127. Vena Caval Replacement With Cadaveric Caval Graft for Living Donor Liver Transplantation in Budd-Chiari Syndrome Associated With Hydatid Cyst Surgery: A Case Report
BALCI D., Kirimker O., Durdu S., HAZİNEDAROĞLU S. M., MEÇO B. C., ÖZÇELİK M., et al.
21st Annual International Congress of the International-Liver-Transplant-Society (ILTS), Illinois, Amerika Birleşik Devletleri, 8 - 11 Temmuz 2015, cilt.99, ss.247-248, (Özet Bildiri)
2015
2015128. Multiple Genetic Mutations Increasing Thrombotic Risk Predisposing Both Donor and Recipient Thrombotic Complications After Living Donor Liver Transplantation: A Case Report
BALCI D., Kirimker O., KONCA C., HAZİNEDAROĞLU S. M., ÖZÇELİK M., MEÇO B. C., et al.
21st Annual International Congress of the International-Liver-Transplant-Society (ILTS), Illinois, Amerika Birleşik Devletleri, 8 - 11 Temmuz 2015, cilt.99, ss.278, (Özet Bildiri)
2015
2015129. The role of genetic variability of pnpla3 (rs738409) on histological progression of non alcoholic fatty liver disease
İdilman R., Keskin O., Karataylı S., Kabaçam G., Tüzün A. E., Savaş B., et al.
24th Annual Conference of APASL, İstanbul, Türkiye, 12 - 15 Mart 2015, ss.373, (Özet Bildiri)
2015
2015130. The role of genetic variability of pnpla3 rs738409 on histological progression of non alcoholic fatty liver disease
İDİLMAN R., KESKİN O., ÖZEN KARATAYLI S. C., KABAÇAM G., TÜZÜN A. E., SAVAŞ B., et al.
24th Annual Conference of APASL, March 12–15, 2015, Istanbul, Turkey, 12 - 15 Mart 2015, cilt.9, ss.373, (Özet Bildiri)
2014
2014131. Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy
SOYDAL Ç., Keskin O., KÜÇÜK N. Ö., Bilgic S., ÖZKAN E., İDİLMAN R., et al.
Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Missouri, Amerika Birleşik Devletleri, 7 - 11 Haziran 2014, cilt.55, (Özet Bildiri)
2014
2014132. Hepatoselüler kanserli hastalarda selektif internal radyasyon tedavisi sonrası sağkalımı öngörmede prognostik faktörler
SOYDAL Ç., KESKİN O., KÜÇÜK N. Ö., İDİLMAN R., ÖZKAN E., BİLGİÇ M. S., et al.
26.Ulusal Nükleer Tıp Kongresi, Türkiye, 16 - 20 Nisan 2014, ss.17, (Özet Bildiri)
2014
2014133. Early on-treatment HDV RNA kinetics are not predicitve for long-term response to a PEG-IFNa therapy of hepatitis delta
Wobse M., Yurdaydin C., Ernst S., Hardtke S., Heidrich B., Bremer B., et al.
65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 7 - 11 Kasım 2014, cilt.60, (Özet Bildiri)
2014
2014134. Prenylation inhibition with lonafarnib decreases hepatitis D levels in humans
Koh C., Yurdaydin C., Cooper S., Cory D., Dahari H., Haynes-Williams V., et al.
65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 7 - 11 Kasım 2014, cilt.60, (Özet Bildiri)
2014
2014135. Timing of hepatocellular carcinoma (HCC) development and predictability of a modified PAGE-B risk score in caucasian chronic hepatitis B (CHB) patients treated with entecavir (ETV) or tenofovir (TDF)
Papatheodoridis G. V., Dalekos G. N., Sypsa V., Yurdaydin C., Buti M., Goulis I., et al.
65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 7 - 11 Kasım 2014, cilt.60, (Özet Bildiri)
2014
2014136. The long-term efficacy of combination of nucleos(t)ide analogue treatment and low dose hepatitis b immunoglobulin on posttransplant HBV recurrence
İDİLMAN R., Akyildiz M., Keskin O., Tuzun A., Yilmaz T. U., Guler N., et al.
65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 7 - 11 Kasım 2014, cilt.60, (Özet Bildiri)
2013
2013137. Inactive hepatitis B carriers are prone to HBsAg loss rather than reactivation: a 5-year prospective follow-up study
Keskin O., Yakut M., Kalkan C., Karatayli S. C., Karatayli E., İDİLMAN R., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri)
2013
2013138. Effectiveness and safety of entecavir and tenofovir in chronic hepatitis b patients: A multicenter Turkish study in clinical practice
İDİLMAN R., GÜNŞAR F., Keskin O., Meral C. E., KORUK M., GÜLŞEN M. T., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri)
2013
2013139. Four years of tenofovir monotherapy for NUC naive field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosis
Lampertico P., Soffredini R., Yurdaydin C., İDİLMAN R., Papatheodoridis G. V., Margariti E., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri)
2013
2013140. Risk and risk factors of hepatocellular carcinoma (HCC) in Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis treated with entecavir (ETV) or tenofovir (TDF)
Papatheodoridis G. V., Dalekos G. N., Yurdaydin C., Goulis I., Arends P., Buti M., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri)
2011
2011141. INTERLEUKIN-28 (IL-28) GENE POLYMORPHISM (RS12979860 C/T) IS ASSOCIATED WITH PROGRESSION TO CHRONIC DELTA HEPATITIS INFECTION
BOZDAYI A. M., ÖZTÜRK T., Altuntas S., Karatayli S. C., Karatayli E., Celik I., et al.
62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 4 - 08 Kasım 2011, cilt.54, (Özet Bildiri)
2010
2010142. IDENTIFICATION OF RISK FACTORS FOR FIBROSIS PROGRESSION IN NON-ALCOHOLIC FATTY LIVER DISEASE
CENGİZ SEVAL G., İDİLMAN R., ÇINAR K., Seven G., Yakut M., Kabacam G., et al.
61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 29 Ekim - 02 Kasım 2010, cilt.52, (Özet Bildiri)
2009
2009143. HBsAg POZİTİF OLAN ALICILARDA ALLOJENİK HEMATOPOETİK HÜCRE TRANSPLANTASYONU
TOPÇUOĞLU P., SOYDAN E., İDİLMAN R., CENGİZ SEVAL G., ÜSTÜN C., ARSLAN Ö., et al.
35. Ulusal Hematoloji Kongresi, 07 Ekim 2009, (Tam Metin Bildiri)
2009
2009144. RENAL TUBULER ACIDOSIS IN LIVER TRANSPLANT RECIPIENTS: THE EFFECT OF CALCINEURIN INHIBITORS.
İDİLMAN R., KARASU A. Z., Cengiz G., KEVEN K., Ersoz S., ŞENGÜL Ş., et al.
15th Annual Congress of the International-Liver-Transplantation-Society, New York, Amerika Birleşik Devletleri, 8 - 11 Temmuz 2009, cilt.15, (Özet Bildiri)
2009
2009145. The burden of chronic hepatitis B in a median endemic country:a mathematical approach
TOY M., ÖNDER F. O., İDİLMAN R., Richardus J. H., BOZDAYI A. M., KULOĞLU Z., et al.
International Liver Congress TM 2009. 44th Annual Meeting of The European Association for the Study of the Liver,Copenhagen, Denmark, 22-26 April, 200, Copenhag, Danimarka, 22 - 26 Nisan 2009, (Özet Bildiri)
2008
2008146. Non-alkolik yağlı karaciğerde endotelyal fonksiyon ve kardiovasküler risk profili
Saykı M., İDİLMAN R., TULUNAY KAYA C., MIZRAK KAYA D., Bıyıklı Z., CENGİZ SEVAL G., et al.
25. Ulusal Gastroenteroloji Haftası, Türkiye, 12 - 16 Kasım 2008, (Tam Metin Bildiri)
2008
2008147. Kronik Viral Hepatitlerde Lenfoproliferatif Hastalıklar
BOZKUŞ Y., İDİLMAN R., MIZRAK KAYA D., CENGİZ SEVAL G., Saykı M., Üstün Y., et al.
25. Ulusal Gastroenteroloji Haftası, Türkiye, 12 - 16 Kasım 2008, (Tam Metin Bildiri)
2008
2008148. Non-Alkolik Yağlı Karaciğer: Uzun Süreli İlaçsız Takipte Doğal Seyir
CENGİZ SEVAL G., İDİLMAN R., ÇINAR K., MIZRAK KAYA D., BOZKUŞ Y., Saykı M., et al.
25. Ulusal Gastroenteroloji Haftası, Türkiye, 12 - 16 Kasım 2008, (Tam Metin Bildiri)
2008
2008149. Kronik Hepatit C’li hastalarda karaciğer fibrozisini göstermede kullanılan biyokimyasal belirteçler ile karaciğer biyopsisinin tanısal değerliliklerinin karşılaştırılması
MIZRAK KAYA D., İDİLMAN R., DOĞANAY ERDOĞAN B., SAVAŞ B., üstün y., Saykı M., et al.
25. Ulusal Gastroenteroloji Haftası, Türkiye, 12 - 16 Kasım 2008, (Tam Metin Bildiri)
2008
2008150. HBEAG-POSITIVE DELTA HEPATITIS: VIROLOGICAL; BIOCHEMICAL AND CLINICAL FEATURES IN A LARGE EUROPEAN MULTICENTER DATA BASE
Heidrich B., Wedemeyer H., Bektas M., İDİLMAN R., Oender F. O., BOZDAYI A. M., et al.
59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Kostarika, 31 Ekim - 04 Kasım 2008, cilt.48, (Özet Bildiri)
2007
2007151. Complete genome sequences and phylogenetic analysis of hepatitis D viruses (HDV) isolated from turkish patients with chronic HDV infection
Emir F., Bektas M., Kesen E., Idilman R., Bozdayi A. M., Yurdaydin C.
58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 2 - 06 Kasım 2007, cilt.46, (Özet Bildiri)
2006
2006152. Transjuguler Intrahepatik Portosistemik Santin Renal Resistivite indeksi Üzerine Etkileri: Erken Sonuclar
CENGİZ SEVAL G., İDİLMAN R., ÇINAR K., KEVEN K., ÇOBAN Ş., BEKTAŞ M., et al.
23. Ulusal Gastroenteroloji Kongresi, 05 Kasım 2006, (Tam Metin Bildiri)
2006
2006153. Potential role of cytokine gene polymorphisms in outcome of chronic delta hepatitis
Ulger Z., Emir F., Arslan-Ergul A., Idilman R., Yalcin K., Uzunalimoglu O., et al.
57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 27 - 31 Ekim 2006, cilt.44, (Özet Bildiri)
2006
2006154. Insulin-sensitizer agents in the treatment of individuals with non-alcoholic steatohepatitis: A preliminary report
Idilman R., Mizrak D., Soykan I., Corapcioglu D., Erden E., Coban S., et al.
57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 27 - 31 Ekim 2006, cilt.44, (Özet Bildiri)
2005
2005155. Treatment of chronic hepatitis D (CHD) with interferon vs. interferon plus lamivudine vs. lamivudine: Short-and long-term results
Yurdaydin C., Bozkaya H., Onder O., Senturk H., Fried M., Idilman R., et al.
56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Kostarika, 11 - 15 Kasım 2005, cilt.42, (Özet Bildiri)
2005
2005156. The fate of recipient-derived repopulated hepatocytes in sex-mismatched liver allograft: A longitudinal study
Idilman R., Erden E., Ersoz S., Kuzu I., Karayalcin S.
56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Kostarika, 11 - 15 Kasım 2005, (Özet Bildiri)
2005
2005157. Potential role of cytokine gene polymorphisms in hepatitis B infection outcome
Arslan-Ergul A., Yurdaydin C., Koytak E., Idilman R., Uzunalimoglu O., Bozdayi A., et al.
40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, Fransa, 13 - 17 Nisan 2005, cilt.42, ss.230, (Özet Bildiri)
2005
2005158. The expression of intestinal trefoil factor in biliary epithelial cells of chronic graft-versus-host disease of the liver in allogeneic hematopoietic stem cell transplants
Idilman R., Erden E., Arat M., Coban S., Erkan O., Tuzun A., et al.
40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, Fransa, 13 - 17 Nisan 2005, ss.236, (Özet Bildiri)
2005
2005159. The effect of tissue injury on donor-derived hepatocyte repopulation following sex-mismatched hematopoietic stem cell transplantation
Idilman R., Soykan I., Erden E., Kuzu I., Arat M., Akyol G., et al.
40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, Fransa, 13 - 17 Nisan 2005, cilt.42, ss.139, (Özet Bildiri)
2005
2005160. The effects of transplantation-related factors and tissue injury on donor-derived cells repopulation following sex-mismatched haematopoietic cell transplantation
Idilman R., Kuzu L., Arat M., Erden E., Soydan E., Soykan I., et al.
31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group, Prague, Çek Cumhuriyeti, 20 - 23 Mart 2005, cilt.35, (Özet Bildiri)
2004
2004161. PPAR-alpha L162V polymorphism in nonalcoholic steatohepatitis.
Verdi H., Koytak E., Ergul A., Idilman R., Uzunalimoglu O., Yurdaydin C., et al.
55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 29 Ekim - 02 Kasım 2004, cilt.40, (Özet Bildiri)
2004
2004162. Hepatit C Virus Enfeksiyonu Olan hastalarda Cinsel İşlev Bozuklukları
BOZTAŞ M. H., İDİLMAN R., ÖZEL KIZIL E. T., TÜZÜN A. E., SOYKAN A., BOZKAYA H., et al.
21. Ulusal Gastroenteroloji Kongresi, Türkiye, 31 Ağustos - 04 Eylül 2004, (Tam Metin Bildiri)
2004
2004163. Recipient-derived hepatocytes in sex-mismatched liver allograft after liver transplantation
Idilman R., Erden E., Kuzu I., Ersoz S., Karayalcin K., KARASU A. Z., et al.
39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Berlin, Almanya, 14 - 18 Nisan 2004, ss.104, (Özet Bildiri)
2003
2003164. Recipient-derived hepatocytes in sex-mismatched living-related partial liver transplants.
Idilman R., Erden E., Kuzu I., Ersoz S., Karayalcin K., Yerdel M., et al.
54th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, BOSTON, MASSACHUSETTS, 24 - 28 Ekim 2003, (Özet Bildiri)
2003
2003165. Lamivudine prophylaxis for prevention of chemotherapy induced hepatitis B virus reactivation in hepatitis B virus carriers with hematological malignancies
Idilman R., Arat M., TÖRÜNER M., Soykan I., Karayalcin S., Soydan E., et al.
38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.146-147, (Özet Bildiri)
2003
2003166. The effect of hepatitis B virus status of the donor on the hepatitis B virus serology of the recipient after allogeneic hematopoietic cell transplantation
Idilman R., Soydan E., Arat M., TÖRÜNER M., Soykan I., Karayalcin S., et al.
38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.146, (Özet Bildiri)
2003
2003167. The effect of mycophenolate mofetil in steroid refractory or dependent chronic graft-versus-host disease
Soydan E., Arat M., Topcuoglu P., Ozcan M., Arslan O., Idilman R., et al.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Türkiye, 23 - 26 Mart 2003, cilt.31, (Özet Bildiri)
2003
2003168. Donor type epithelial cell repopulation in gastrointestinal mucosa following sex mismatch allogeneic peripheral blood transplantation: evidence for in vivo stem cell plasticity?
Kuzu I., Idilman R., Arat M., Dalva K., Soykan I., Akan H., et al.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Türkiye, 23 - 26 Mart 2003, (Özet Bildiri)
2003
2003169. The effect of hepatitis B virus status of donor on the hepatitis B virus serology of recipient after allogeneic hematopoietic cell transplantation
Soydan E., Idilman R., Arat M., Karayalcin S., Ustun C., Ozcan M., et al.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Türkiye, 23 - 26 Mart 2003, cilt.31, (Özet Bildiri)
2002
2002170. The efficciency of ursodeoxycholic acid in treatment of limited chronic graft versus host disease of the liver.
Arat M., Idilman R., Soydan E., TÖRÜNER M., Akan H.
44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 6 - 10 Aralık 2002, cilt.100, (Özet Bildiri)
2002
2002171. The long-term ursodeoxycholic acid treatment of chronic graft-versus-host disease of the liver.
Idilman R., Arat M., TÖRÜNER M., Soydan E., Soykan I., Erden E., et al.
53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON, MASSACHUSETTS, 1 - 05 Kasım 2002, cilt.36, (Özet Bildiri)
Kitaplar
2018
20181. Türkiye Viral Hepatit Önleme ve Kontrol Programı” “Sağlık Bakanlığı Yayın No, Ankara
AKARCA U. S., AKINCI E., AKYILDIZ M., BAYKAM N., BEŞIŞIK S. F., BODUR H., et al.
Sağlık Bakanlığı yayını Ankara, Ankara, 2018
Desteklenen Projeler
2026 - Devam Ediyor
2026 - Devam EdiyorMetabolik bozuklukla ilişkili yağlı karaciğer hastalığı (MASLD) olanların birinci derece yakınlarında MASLD sıklığının belirlenmesi ve hastalığa etki eden faktörlerin ortaya konulması
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
GÖKCAN H. (Yürütücü), TURAN GÖKÇE D., İDİLMAN R., AKARCA H. T., YILMAZ V., TUNÇ E., et al.
2025 - Devam Ediyor
2025 - Devam EdiyorAntiviral Tedavi Alan Kronik Hepatit B Hastasının Hastalık Seyrini Belirlemede HBs antijen titresi HBV DNA ve HBV RNA düzeyinin rolü
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
MELEKOĞLU ELLİK Z. (Yürütücü), YILMAZ V., TUNÇ E., İDİLMAN R.
2025 - Devam Ediyor
2025 - Devam EdiyorAlkol ilişkili karaciğer hastalığının seyrinde moleküler temele dair yeni iç görüler
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
TURAN GÖKÇE D. (Yürütücü), AKARCA H. T., TUNÇ E., İDİLMAN R., YILMAZ V., AYDIN R. F., et al.
2025 - Devam Ediyor
2025 - Devam EdiyorKronik Karaciğer Hastalıkları Etiyolojisi ve Hepatoselüler Kanser Birlikteliği Hastalık Seyrine Etki Eden Faktörlerin Belirlenmesi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
İDİLMAN R. (Yürütücü), TUNÇ E., BAŞARIR E. N.
2025 - Devam Ediyor
2025 - Devam EdiyorDiyabetik Hastalarda Metabolik Bozukluk İlişkili Yağlı Karaciğer Hastalığı MASLD Sıklığı: MASLD'nin Diyabet Seyrine Ve Komplikasyonların Gelişimine Etkisi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
MELEKOĞLU ELLİK Z. (Yürütücü), ŞAH ÜNAL F. T., ŞAHİN M., İDİLMAN R., KURU ÖZ D.
2023 - 2024
2023 - 2024Hepatoselüler karsinom (HCC) görüntülemesinde Ga-68 PSMA PET'in klinik katkısının değerlendirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
ÖZKAN E. (Yürütücü), SOYDAL Ç., TÜZÜNER A., ARAZ M., KÜÇÜK N. Ö., ELHAN A. H., et al.
2023 - 2024
2023 - 2024Hepatoselüler karsinom (HCC) görüntülemesinde Ga-68 PSMA PET'in klinik katkısının değerlendirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
ÖZKAN E. (Yürütücü), SOYDAL Ç., TÜZÜNER A., ARAZ M., KÜÇÜK N. Ö., ELHAN A. H., et al.
2021 - 2024
2021 - 2024Siroz Hastalarında Düzenli Beslenmenin Sarkopeni Üzerine Etkisi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
İDİLMAN R. (Yürütücü)
2018 - 2020
2018 - 2020Alkol dışı yağlı karaciğer hastalığında kardiak ve kardiovasküler hastalık varlığını önceden saptanması: Subklinik myokardial disfonksiyon
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
İDİLMAN R. (Yürütücü)
2018 - 2018
2018 - 2018PLASMA METABOLOMIC CHANGES MODULATE THE IMPACT OF MIDDLE EASTERN VERSUS WESTERN DIET IN AN INTERNATIONAL CIRRHOSIS COHORT
Diğer Resmi Kurumlarca Desteklenen Proje
İDİLMAN R. (Yürütücü)
2017 - 2018
2017 - 2018Protocol of the Predicting Acute on Chronic Liver Failure in Cirrhosis
Diğer Uluslararası Fon Programları
İDİLMAN R.
2010 - 2013
2010 - 2013İnsülün direnci olan non-alkolik yağlı karaciğer (NAYK) hastalarında, diyet ve egzersizin endotelyal fonksiyon bozukluğu ve kardiyovasküler risk profili üzerine etkisinin belirlenmesi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
İDİLMAN R. (Yürütücü)